| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | TSHZ3 HDAC4 NSD1 SMARCAD1 RUVBL2 CREBBP ZFX ZFY PRDM1 MSH6 SMARCA2 KMT2A SLC30A9 PRDM15 EP300 | 7.32e-06 | 739 | 105 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coregulator activity | HDAC4 KDM4C NSD1 KMT2E RUVBL2 CREBBP CEBPZ ZNF451 BRD7 SMARCA2 TMF1 SLC30A9 EP300 | 7.93e-06 | 562 | 105 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription factor binding | BDP1 HDAC4 KDM4C PCLO NSD1 RUVBL2 CREBBP IKZF4 GTF2I BRD7 TMF1 PDCD11 KMT2A SLC30A9 EP300 | 9.15e-06 | 753 | 105 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.63e-05 | 33 | 105 | 4 | GO:0050681 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 2.74e-05 | 2 | 105 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 2.74e-05 | 2 | 105 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.18e-05 | 303 | 105 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | histone binding | 7.95e-05 | 265 | 105 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 8.19e-05 | 3 | 105 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | insulin-like growth factor receptor activity | 8.19e-05 | 3 | 105 | 2 | GO:0005010 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.09e-04 | 229 | 105 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | HDAC4 KDM4C NSD1 CREBBP IKZF4 GTF2I TMF1 PDCD11 KMT2A SLC30A9 EP300 | 2.46e-04 | 582 | 105 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 3.56e-04 | 417 | 105 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX47 AK9 SMARCAD1 RUVBL2 MSH6 DNAH12 MDN1 SMARCA2 KIF13A DDX21 ATP2B1 | 3.87e-04 | 614 | 105 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | beta-catenin binding | 4.31e-04 | 120 | 105 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.33e-04 | 441 | 105 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 5.39e-04 | 126 | 105 | 5 | GO:0051082 | |
| GeneOntologyMolecularFunction | chromatin insulator sequence binding | 5.65e-04 | 7 | 105 | 2 | GO:0043035 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 5.71e-04 | 31 | 105 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 7.73e-04 | 206 | 105 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 9.64e-04 | 37 | 105 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 9.64e-04 | 83 | 105 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | HDAC4 KDM4C NSD1 SPAG9 KMT2E RUVBL2 CREBBP CEBPZ ZNF451 G3BP2 BRD7 SMARCA2 TMF1 SLC30A9 EP300 | 1.07e-03 | 1160 | 105 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.33e-03 | 229 | 105 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | helicase activity | 1.49e-03 | 158 | 105 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.60e-03 | 44 | 105 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.90e-03 | 167 | 105 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | calcium ion binding | SPARC CLGN MATN2 CANX PCLO RYR2 TCHHL1 TNNC2 CDH9 DNASE1L3 CDH11 | 1.95e-03 | 749 | 105 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | cadherin binding | 2.10e-03 | 339 | 105 | 7 | GO:0045296 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.63e-03 | 262 | 105 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.75e-03 | 15 | 105 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.10e-03 | 187 | 105 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 4.08e-03 | 61 | 105 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 4.33e-03 | 599 | 105 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 4.42e-03 | 19 | 105 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | SUMO binding | 4.42e-03 | 19 | 105 | 2 | GO:0032183 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.55e-03 | 127 | 105 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 4.67e-03 | 64 | 105 | 3 | GO:0140296 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | HDAC4 KDM4C NSD1 SPAG9 KMT2E RUVBL2 CREBBP CEBPZ ZNF451 G3BP2 BRD7 SMARCA2 TMF1 SLC30A9 EP300 | 4.82e-03 | 1356 | 105 | 15 | GO:0060090 |
| GeneOntologyMolecularFunction | methyltransferase activity | 5.37e-03 | 213 | 105 | 5 | GO:0008168 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 5.39e-03 | 21 | 105 | 2 | GO:0042975 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CCPG1 HDAC4 KDM4C RPS6KA3 MYT1 RUVBL2 CREBBP IKZF4 ZFX ZFY GTF2I CEBPZ SMARCA2 TMF1 KMT2A SLC30A9 HSF2 DDX21 PRDM15 EP300 | 1.32e-05 | 1390 | 102 | 20 | GO:0045944 |
| GeneOntologyBiologicalProcess | chromatin remodeling | HDAC4 KDM4C NSD1 NASP SMARCAD1 KMT2E RUVBL2 CREBBP ZFY BRD7 SMARCA2 KMT2A DDX21 EP300 | 1.68e-05 | 741 | 102 | 14 | GO:0006338 |
| GeneOntologyBiologicalProcess | post-embryonic development | 5.66e-05 | 135 | 102 | 6 | GO:0009791 | |
| GeneOntologyBiologicalProcess | DNA repair | PDS5B SMARCAD1 RUVBL2 CREBBP LIG1 MSH6 BRD7 SMARCA2 BOD1L1 SLC30A9 USP1 RNF111 | 8.55e-05 | 648 | 102 | 12 | GO:0006281 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 HDAC4 KDM4C NSD1 NASP SMARCAD1 KMT2E RUVBL2 CREBBP ZFY BRD7 SMARCA2 KMT2A DDX21 EP300 | 1.15e-04 | 999 | 102 | 15 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | HDAC4 KDM4C NSD1 NASP SMARCAD1 KMT2E RUVBL2 CREBBP ZFY BRD7 SMARCA2 KMT2A DDX21 EP300 | 1.31e-04 | 896 | 102 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.44e-04 | 4 | 102 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 1.67e-04 | 104 | 102 | 5 | GO:0030516 | |
| GeneOntologyBiologicalProcess | response to UV | 1.83e-04 | 167 | 102 | 6 | GO:0009411 | |
| GeneOntologyCellularComponent | chromatin | PDS5B TSHZ3 ERF HDAC4 KDM4C MYT1 NSD1 NASP SMARCAD1 KMT2E RUVBL2 CREBBP ZFX ZFY MSH6 BRD7 SMARCA2 HSF2 DDX21 EP300 | 3.12e-05 | 1480 | 103 | 20 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | UTP6 RANBP1 WDR36 HDAC4 TAF1A NSD1 RBM28 KMT2E RUVBL2 CREBBP EFTUD2 MSH6 MFAP1 CEBPZ BRD7 SMARCA2 KMT2A BOD1L1 DDX21 | 3.84e-05 | 1377 | 103 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | methyltransferase complex | 1.96e-04 | 108 | 103 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | Pwp2p-containing subcomplex of 90S preribosome | 3.56e-04 | 6 | 103 | 2 | GO:0034388 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 5.17e-04 | 75 | 103 | 4 | GO:0035097 | |
| GeneOntologyCellularComponent | ribbon synapse | 5.19e-04 | 32 | 103 | 3 | GO:0097470 | |
| HumanPheno | Abnormal columella morphology | 4.89e-07 | 97 | 39 | 8 | HP:0009929 | |
| HumanPheno | Abnormal nasal septum morphology | 1.81e-06 | 115 | 39 | 8 | HP:0000419 | |
| HumanPheno | Hypoplasia of the maxilla | 4.67e-05 | 130 | 39 | 7 | HP:0000327 | |
| HumanPheno | Aplasia/Hypoplasia of the maxilla | 5.41e-05 | 133 | 39 | 7 | HP:0009117 | |
| HumanPheno | Plantar crease between first and second toes | 5.71e-05 | 2 | 39 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 5.71e-05 | 2 | 39 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 5.71e-05 | 2 | 39 | 2 | HP:0001042 | |
| HumanPheno | Short columella | 6.07e-05 | 29 | 39 | 4 | HP:0002000 | |
| HumanPheno | Broad eyebrow | 6.07e-05 | 29 | 39 | 4 | HP:0011229 | |
| HumanPheno | Pectus excavatum | ERF RPS6KA3 NSD1 CREBBP IGF1R GTF2I KMT2A ATP2B1 EP300 CDH11 | 1.11e-04 | 323 | 39 | 10 | HP:0000767 |
| HumanPheno | Abnormal number of permanent teeth | 1.30e-04 | 35 | 39 | 4 | HP:0011044 | |
| HumanPheno | Highly arched eyebrow | 1.30e-04 | 206 | 39 | 8 | HP:0002553 | |
| HumanPheno | Hypoplastic facial bones | ERF HDAC4 RPS6KA3 COBLL1 CREBBP EFTUD2 GTF2I HERC1 EP300 CDH11 | 1.36e-04 | 331 | 39 | 10 | HP:0002692 |
| HumanPheno | Thick eyebrow | 1.37e-04 | 154 | 39 | 7 | HP:0000574 | |
| HumanPheno | Aplasia/Hypoplasia of facial bones | ERF HDAC4 RPS6KA3 COBLL1 CREBBP EFTUD2 GTF2I HERC1 EP300 CDH11 | 1.40e-04 | 332 | 39 | 10 | HP:0034261 |
| HumanPheno | Dental malocclusion | 1.49e-04 | 156 | 39 | 7 | HP:0000689 | |
| HumanPheno | Abnormal maxilla morphology | 1.61e-04 | 158 | 39 | 7 | HP:0000326 | |
| HumanPheno | Laryngeal cartilage malformation | 1.71e-04 | 3 | 39 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.71e-04 | 3 | 39 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.71e-04 | 3 | 39 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.71e-04 | 3 | 39 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.71e-04 | 3 | 39 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.71e-04 | 3 | 39 | 2 | HP:0005895 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | ERF HDAC4 L1CAM RBM28 CREBBP EFTUD2 IGF1R GTF2I SMARCA2 KMT2A ATP2B1 EP300 CDH11 | 1.74e-04 | 564 | 39 | 13 | HP:0009484 |
| HumanPheno | Abnormality of the middle ear | BDP1 CNNM2 RIPOR2 ERF HDAC4 RPS6KA3 COBLL1 TAF1A NSD1 CREBBP RYR2 EFTUD2 LIG1 GTF2I NDUFAF1 MS4A1 RP1L1 KMT2A SLC30A9 DNASE1L3 EP300 CDH11 | 2.14e-04 | 1446 | 39 | 22 | HP:0000370 |
| HumanPheno | Deviation of toes | 2.38e-04 | 118 | 39 | 6 | HP:0100498 | |
| HumanPheno | Kyphosis | SPARC HDAC4 RPS6KA3 L1CAM NSD1 AK9 RBM28 KMT2E GTF2I NDUFAF1 HERC1 CDH11 | 2.77e-04 | 510 | 39 | 12 | HP:0002808 |
| HumanPheno | Trichiasis | 3.39e-04 | 4 | 39 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 3.39e-04 | 4 | 39 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 3.39e-04 | 4 | 39 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 3.39e-04 | 4 | 39 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 3.39e-04 | 4 | 39 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 3.39e-04 | 4 | 39 | 2 | HP:0031207 | |
| HumanPheno | Radial deviation of finger | ERF HDAC4 L1CAM CREBBP IGF1R GTF2I SMARCA2 KMT2A ATP2B1 EP300 CDH11 | 3.72e-04 | 448 | 39 | 11 | HP:0009466 |
| HumanPheno | Advanced eruption of teeth | 3.80e-04 | 46 | 39 | 4 | HP:0006288 | |
| HumanPheno | Blepharophimosis | 3.86e-04 | 129 | 39 | 6 | HP:0000581 | |
| HumanPheno | Short phalanx of finger | 3.86e-04 | 306 | 39 | 9 | HP:0009803 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | ERF HDAC4 L1CAM CREBBP IGF1R GTF2I SMARCA2 KMT2A ATP2B1 EP300 CDH11 | 4.34e-04 | 456 | 39 | 11 | HP:0009485 |
| HumanPheno | Deviation of finger | ERF HDAC4 L1CAM CREBBP EFTUD2 IGF1R GTF2I SMARCA2 KMT2A ATP2B1 EP300 CDH11 | 4.49e-04 | 537 | 39 | 12 | HP:0004097 |
| HumanPheno | Deviation of the hallux | 4.97e-04 | 88 | 39 | 5 | HP:0010051 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 5.25e-04 | 319 | 39 | 9 | HP:0009767 | |
| HumanPheno | Periorbital wrinkles | 5.63e-04 | 5 | 39 | 2 | HP:0000607 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 5.63e-04 | 5 | 39 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 5.63e-04 | 5 | 39 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 5.63e-04 | 5 | 39 | 2 | HP:0030421 | |
| HumanPheno | Abnormal sternum morphology | ERF HDAC4 RPS6KA3 NSD1 CREBBP IGF1R GTF2I KMT2A ATP2B1 EP300 CDH11 | 6.05e-04 | 474 | 39 | 11 | HP:0000766 |
| HumanPheno | Prominent forehead | 6.55e-04 | 261 | 39 | 8 | HP:0011220 | |
| HumanPheno | Agenesis of permanent teeth | 6.61e-04 | 23 | 39 | 3 | HP:0006349 | |
| HumanPheno | Narrow palate | 7.25e-04 | 202 | 39 | 7 | HP:0000189 | |
| HumanPheno | Sandal gap | 7.42e-04 | 96 | 39 | 5 | HP:0001852 | |
| HumanPheno | Low hanging columella | 8.10e-04 | 56 | 39 | 4 | HP:0009765 | |
| HumanPheno | Large foramen magnum | 8.40e-04 | 6 | 39 | 2 | HP:0002700 | |
| HumanPheno | Clinodactyly of the 5th finger | ERF HDAC4 L1CAM CREBBP GTF2I SMARCA2 KMT2A ATP2B1 EP300 CDH11 | 9.35e-04 | 420 | 39 | 10 | HP:0004209 |
| HumanPheno | Clinodactyly of hands | ERF HDAC4 L1CAM CREBBP GTF2I SMARCA2 KMT2A ATP2B1 EP300 CDH11 | 9.53e-04 | 421 | 39 | 10 | HP:0001157 |
| HumanPheno | Deviation of the 5th finger | ERF HDAC4 L1CAM CREBBP GTF2I SMARCA2 KMT2A ATP2B1 EP300 CDH11 | 9.53e-04 | 421 | 39 | 10 | HP:0009179 |
| HumanPheno | Phonophobia | 9.55e-04 | 26 | 39 | 3 | HP:0002183 | |
| HumanPheno | Broad distal phalanx of finger | 1.07e-03 | 27 | 39 | 3 | HP:0009836 | |
| HumanPheno | Delayed skeletal maturation | 1.07e-03 | 352 | 39 | 9 | HP:0002750 | |
| HumanPheno | Brachydactyly (hand) | ERF HDAC4 RPS6KA3 NSD1 CREBBP IGF1R SMARCA2 KMT2A EP300 CDH11 | 1.12e-03 | 430 | 39 | 10 | HP:0100667 |
| HumanPheno | Flat face | 1.16e-03 | 106 | 39 | 5 | HP:0012368 | |
| HumanPheno | Broad nasal tip | 1.17e-03 | 159 | 39 | 6 | HP:0000455 | |
| HumanPheno | Deviated nasal septum | 1.17e-03 | 7 | 39 | 2 | HP:0004411 | |
| HumanPheno | Abnormal incisor morphology | 1.19e-03 | 62 | 39 | 4 | HP:0011063 | |
| HumanPheno | Long foot | 1.19e-03 | 28 | 39 | 3 | HP:0001833 | |
| HumanPheno | Chiari malformation | 1.21e-03 | 107 | 39 | 5 | HP:0002308 | |
| HumanPheno | Abnormality of the incisor | 1.27e-03 | 108 | 39 | 5 | HP:0000676 | |
| HumanPheno | Abnormality of the palpebral fissures | HDAC4 RPS6KA3 PCLO NSD1 KMT2E CREBBP EFTUD2 IGF1R GTF2I SMARCA2 KMT2A HERC1 SLC30A9 EP300 CDH11 | 1.32e-03 | 880 | 39 | 15 | HP:0008050 |
| HumanPheno | Tooth agenesis | 1.34e-03 | 363 | 39 | 9 | HP:0009804 | |
| HumanPheno | Emphysema | 1.34e-03 | 64 | 39 | 4 | HP:0002097 | |
| HumanPheno | Abnormal hand morphology | SPARC ERF HDAC4 RPS6KA3 L1CAM NSD1 RBM28 CREBBP EFTUD2 IGF1R GTF2I SMARCA2 KMT2A HERC1 ATP2B1 EP300 CDH11 | 1.36e-03 | 1082 | 39 | 17 | HP:0005922 |
| HumanPheno | Pes planus | 1.39e-03 | 365 | 39 | 9 | HP:0001763 | |
| HumanPheno | Hypodontia | 1.52e-03 | 229 | 39 | 7 | HP:0000668 | |
| HumanPheno | Abnormal midface morphology | ERF HDAC4 RPS6KA3 COBLL1 PCLO KMT2E CREBBP EFTUD2 GTF2I SMARCA2 HERC1 EP300 CDH11 | 1.53e-03 | 704 | 39 | 13 | HP:0000309 |
| HumanPheno | Short phalanx of hallux | 1.55e-03 | 8 | 39 | 2 | HP:0010111 | |
| HumanPheno | Conductive hearing impairment | 1.62e-03 | 373 | 39 | 9 | HP:0000405 | |
| HumanPheno | Finger clinodactyly | ERF HDAC4 L1CAM CREBBP GTF2I SMARCA2 KMT2A ATP2B1 EP300 CDH11 | 1.65e-03 | 452 | 39 | 10 | HP:0040019 |
| MousePheno | abnormal prenatal growth/weight/body size | PDS5B RANBP1 CNNM2 ERF ZC3H13 NASP SMARCAD1 CREBBP RYR2 ZFX ZFY EFTUD2 PRDM1 LIG1 IGF1R GTF2I IGF2R BRD7 SLC30A9 DDX21 SUCO PRDM15 EP300 | 2.35e-05 | 1493 | 86 | 23 | MP:0004196 |
| MousePheno | decreased oocyte number | 2.55e-05 | 95 | 86 | 6 | MP:0005431 | |
| MousePheno | decreased hematopoietic stem cell number | 2.55e-05 | 57 | 86 | 5 | MP:0004810 | |
| MousePheno | abnormal oocyte number | 2.71e-05 | 96 | 86 | 6 | MP:0020152 | |
| MousePheno | prenatal growth retardation | PDS5B CNNM2 ERF ZC3H13 CREBBP RYR2 EFTUD2 PRDM1 LIG1 IGF1R GTF2I BRD7 SLC30A9 DDX21 PRDM15 EP300 | 6.87e-05 | 869 | 86 | 16 | MP:0010865 |
| MousePheno | reduced female fertility | 8.36e-05 | 296 | 86 | 9 | MP:0001923 | |
| MousePheno | delayed bone ossification | 1.30e-04 | 127 | 86 | 6 | MP:0000060 | |
| MousePheno | abnormal germ cell morphology | PDS5B RANBP1 AMPH MAP2 SPAG9 SMARCAD1 KMT2E ZFX ZFY PRDM1 BRD7 TMF1 CFAP119 HSF2 USP1 IQCG | 1.85e-04 | 946 | 86 | 16 | MP:0002208 |
| MousePheno | abnormal craniofacial morphology | PDS5B RANBP1 CNNM2 SPARC ERF HDAC4 RPS6KA3 COBLL1 L1CAM CREBBP PRDM1 IGF1R GTF2I IGF2R KMT2A SLC30A9 SUCO USP1 EP300 CDH11 | 1.96e-04 | 1372 | 86 | 20 | MP:0000428 |
| MousePheno | craniofacial phenotype | PDS5B RANBP1 CNNM2 SPARC ERF HDAC4 RPS6KA3 COBLL1 L1CAM CREBBP PRDM1 IGF1R GTF2I IGF2R KMT2A SLC30A9 SUCO USP1 EP300 CDH11 | 1.96e-04 | 1372 | 86 | 20 | MP:0005382 |
| MousePheno | abnormal foam cell morphology | PDS5B RANBP1 AMPH MAP2 SPAG9 SMARCAD1 KMT2E ZFX ZFY PRDM1 BRD7 TMF1 CFAP119 HSF2 USP1 IQCG | 2.04e-04 | 954 | 86 | 16 | MP:0009840 |
| MousePheno | abnormal oocyte morphology | 2.04e-04 | 138 | 86 | 6 | MP:0001125 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | PDS5B RANBP1 TSHZ3 CNNM2 HDAC4 MYT1 L1CAM KMT2E CREBBP RYR2 ZFX ZFY LIG1 IGF1R IGF2R BRD7 KMT2A SUCO EP300 | 2.08e-04 | 1269 | 86 | 19 | MP:0011111 |
| MousePheno | abnormal male germ cell morphology | PDS5B RANBP1 AMPH MAP2 SPAG9 KMT2E ZFX ZFY PRDM1 BRD7 TMF1 CFAP119 HSF2 USP1 IQCG | 2.14e-04 | 859 | 86 | 15 | MP:0006362 |
| MousePheno | broad nasal bridge | 2.23e-04 | 4 | 86 | 2 | MP:0000449 | |
| MousePheno | abnormal embryonic growth/weight/body size | RANBP1 CNNM2 ERF ZC3H13 NASP SMARCAD1 CREBBP RYR2 ZFX ZFY EFTUD2 PRDM1 LIG1 GTF2I IGF2R SLC30A9 DDX21 PRDM15 EP300 | 2.70e-04 | 1295 | 86 | 19 | MP:0002088 |
| MousePheno | decreased germ cell number | PDS5B RANBP1 MAP2 SPAG9 SMARCAD1 ZFX ZFY PRDM1 BRD7 CFAP119 HSF2 USP1 IQCG | 2.75e-04 | 687 | 86 | 13 | MP:0002209 |
| MousePheno | postnatal lethality | HDAC4 CANX MYT1 L1CAM SMARCAD1 KMT2E SHTN1 CREBBP RYR2 ZFX ZFY PRDM1 IGF2R HSF2 SUCO USP1 EP300 | 2.78e-04 | 1084 | 86 | 17 | MP:0002082 |
| MousePheno | abnormal female germ cell morphology | 3.20e-04 | 150 | 86 | 6 | MP:0006361 | |
| MousePheno | lethality throughout fetal growth and development | 3.29e-04 | 435 | 86 | 10 | MP:0006208 | |
| MousePheno | abnormal prenatal body size | RANBP1 ERF ZC3H13 NASP SMARCAD1 CREBBP ZFX ZFY PRDM1 LIG1 GTF2I IGF2R BRD7 SLC30A9 SUCO PRDM15 EP300 | 3.91e-04 | 1116 | 86 | 17 | MP:0010866 |
| MousePheno | postnatal lethality, complete penetrance | 3.93e-04 | 445 | 86 | 10 | MP:0011085 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | PDS5B CANX SMARCAD1 KMT2E SHTN1 CREBBP RYR2 ZFX ZFY EFTUD2 PRDM1 IGF2R KMT2A HSF2 SUCO USP1 EP300 | 4.25e-04 | 1124 | 86 | 17 | MP:0011112 |
| MousePheno | decreased male germ cell number | PDS5B RANBP1 MAP2 SPAG9 ZFX ZFY PRDM1 BRD7 CFAP119 HSF2 USP1 IQCG | 5.24e-04 | 640 | 86 | 12 | MP:0004901 |
| MousePheno | premature bone ossification | 5.28e-04 | 26 | 86 | 3 | MP:0003416 | |
| MousePheno | abnormal hematopoietic stem cell morphology | 6.27e-04 | 112 | 86 | 5 | MP:0004808 | |
| MousePheno | abnormal spermiogenesis | 6.35e-04 | 237 | 86 | 7 | MP:0001932 | |
| MousePheno | abnormal embryo size | RANBP1 ERF ZC3H13 NASP SMARCAD1 CREBBP ZFX ZFY PRDM1 LIG1 GTF2I IGF2R SLC30A9 PRDM15 EP300 | 6.67e-04 | 956 | 86 | 15 | MP:0001697 |
| MousePheno | abnormal bone ossification | 7.06e-04 | 395 | 86 | 9 | MP:0008271 | |
| MousePheno | abnormal gametogenesis | PDS5B RANBP1 AMPH MAP2 SPAG9 SMARCAD1 KMT2E ZFX ZFY PRDM1 BRD7 TMF1 CFAP119 HSF2 USP1 IQCG | 7.29e-04 | 1070 | 86 | 16 | MP:0001929 |
| MousePheno | short sternum | 7.32e-04 | 29 | 86 | 3 | MP:0004321 | |
| MousePheno | decreased primordial germ cell number | 7.32e-04 | 29 | 86 | 3 | MP:0008392 | |
| MousePheno | embryonic growth retardation | CNNM2 ERF ZC3H13 CREBBP RYR2 EFTUD2 PRDM1 LIG1 GTF2I SLC30A9 DDX21 PRDM15 EP300 | 7.45e-04 | 763 | 86 | 13 | MP:0003984 |
| MousePheno | postnatal lethality, incomplete penetrance | CANX SMARCAD1 KMT2E SHTN1 CREBBP ZFX ZFY PRDM1 IGF2R HSF2 USP1 EP300 | 7.75e-04 | 669 | 86 | 12 | MP:0011086 |
| Domain | BROMODOMAIN_2 | 3.11e-06 | 41 | 104 | 5 | PS50014 | |
| Domain | Bromodomain | 3.51e-06 | 42 | 104 | 5 | IPR001487 | |
| Domain | BROMO | 3.51e-06 | 42 | 104 | 5 | SM00297 | |
| Domain | - | 3.51e-06 | 42 | 104 | 5 | 1.20.920.10 | |
| Domain | SET | 5.56e-06 | 46 | 104 | 5 | SM00317 | |
| Domain | SET_dom | 8.44e-06 | 50 | 104 | 5 | IPR001214 | |
| Domain | SET | 8.44e-06 | 50 | 104 | 5 | PS50280 | |
| Domain | Nuc_rcpt_coact_CREBbp | 3.07e-05 | 2 | 104 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 3.07e-05 | 2 | 104 | 2 | SM00551 | |
| Domain | - | 3.07e-05 | 2 | 104 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 3.07e-05 | 2 | 104 | 2 | IPR010303 | |
| Domain | - | 3.07e-05 | 2 | 104 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 3.07e-05 | 2 | 104 | 2 | PF09030 | |
| Domain | zf-TAZ | 3.07e-05 | 2 | 104 | 2 | PF02135 | |
| Domain | ZF_TAZ | 3.07e-05 | 2 | 104 | 2 | PS50134 | |
| Domain | KAT11 | 3.07e-05 | 2 | 104 | 2 | SM01250 | |
| Domain | Znf_TAZ | 3.07e-05 | 2 | 104 | 2 | IPR000197 | |
| Domain | KIX | 3.07e-05 | 2 | 104 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 3.07e-05 | 2 | 104 | 2 | PF08214 | |
| Domain | KIX | 3.07e-05 | 2 | 104 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 3.07e-05 | 2 | 104 | 2 | IPR031162 | |
| Domain | DUF902 | 3.07e-05 | 2 | 104 | 2 | PF06001 | |
| Domain | - | 3.07e-05 | 2 | 104 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 3.07e-05 | 2 | 104 | 2 | IPR013178 | |
| Domain | KIX_dom | 3.07e-05 | 2 | 104 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 3.07e-05 | 2 | 104 | 2 | PS51727 | |
| Domain | BROMODOMAIN_1 | 5.20e-05 | 37 | 104 | 4 | PS00633 | |
| Domain | Bromodomain | 5.79e-05 | 38 | 104 | 4 | PF00439 | |
| Domain | SET | 7.84e-05 | 41 | 104 | 4 | PF00856 | |
| Domain | - | 9.18e-05 | 3 | 104 | 2 | 2.10.250.10 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 9.18e-05 | 3 | 104 | 2 | IPR006794 | |
| Domain | Zfx_Zfy_act | 9.18e-05 | 3 | 104 | 2 | PF04704 | |
| Domain | CALRETICULIN_REPEAT | 9.18e-05 | 3 | 104 | 2 | PS00805 | |
| Domain | Calret/calnex | 1.83e-04 | 4 | 104 | 2 | IPR001580 | |
| Domain | CALRETICULIN_1 | 1.83e-04 | 4 | 104 | 2 | PS00803 | |
| Domain | CALRETICULIN_2 | 1.83e-04 | 4 | 104 | 2 | PS00804 | |
| Domain | Calret/calnex_CS | 1.83e-04 | 4 | 104 | 2 | IPR018124 | |
| Domain | Calreticulin | 1.83e-04 | 4 | 104 | 2 | PF00262 | |
| Domain | Calreticulin/calnexin_P_dom | 3.04e-04 | 5 | 104 | 2 | IPR009033 | |
| Domain | Bromodomain_CS | 3.97e-04 | 26 | 104 | 3 | IPR018359 | |
| Domain | AT_hook | 4.45e-04 | 27 | 104 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 4.45e-04 | 27 | 104 | 3 | IPR017956 | |
| Domain | Nuc_rcpt_coact | 4.54e-04 | 6 | 104 | 2 | IPR009110 | |
| Domain | HAT | 1.34e-03 | 10 | 104 | 2 | SM00386 | |
| Domain | HAT | 1.34e-03 | 10 | 104 | 2 | IPR003107 | |
| Domain | Znf_FYVE_PHD | 1.39e-03 | 147 | 104 | 5 | IPR011011 | |
| Domain | PHD | 1.54e-03 | 89 | 104 | 4 | SM00249 | |
| Domain | Znf_PHD | 1.67e-03 | 91 | 104 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.96e-03 | 95 | 104 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.04e-03 | 96 | 104 | 4 | PS01359 | |
| Domain | ATPase_dyneun-rel_AAA | 2.68e-03 | 14 | 104 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.68e-03 | 14 | 104 | 2 | PF07728 | |
| Domain | Helicase_C | 3.02e-03 | 107 | 104 | 4 | PF00271 | |
| Domain | HELICc | 3.02e-03 | 107 | 104 | 4 | SM00490 | |
| Domain | Helicase_C | 3.12e-03 | 108 | 104 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 3.23e-03 | 109 | 104 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.23e-03 | 109 | 104 | 4 | PS51192 | |
| Domain | DEXDc | 3.23e-03 | 109 | 104 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.33e-03 | 110 | 104 | 4 | IPR014001 | |
| Domain | Post-SET_dom | 3.50e-03 | 16 | 104 | 2 | IPR003616 | |
| Domain | PostSET | 3.50e-03 | 16 | 104 | 2 | SM00508 | |
| Domain | POST_SET | 3.50e-03 | 16 | 104 | 2 | PS50868 | |
| Domain | ZF_ZZ_2 | 4.43e-03 | 18 | 104 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 4.43e-03 | 18 | 104 | 2 | PS01357 | |
| Domain | ZZ | 4.43e-03 | 18 | 104 | 2 | PF00569 | |
| Domain | Znf_ZZ | 4.94e-03 | 19 | 104 | 2 | IPR000433 | |
| Domain | GAGE | 4.94e-03 | 19 | 104 | 2 | IPR031320 | |
| Domain | GAGE | 4.94e-03 | 19 | 104 | 2 | SM01379 | |
| Domain | ZnF_ZZ | 4.94e-03 | 19 | 104 | 2 | SM00291 | |
| Domain | PWWP | 5.47e-03 | 20 | 104 | 2 | SM00293 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 2.26e-04 | 21 | 81 | 3 | M39593 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.22e-04 | 5 | 81 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 3.22e-04 | 5 | 81 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 3.22e-04 | 5 | 81 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 3.22e-04 | 5 | 81 | 2 | M27228 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 3.28e-04 | 301 | 81 | 8 | MM15983 | |
| Pathway | REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL | 3.86e-04 | 60 | 81 | 4 | M27613 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 4.32e-04 | 26 | 81 | 3 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 4.32e-04 | 26 | 81 | 3 | M32 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 4.82e-04 | 6 | 81 | 2 | M22062 | |
| Pathway | REACTOME_RUNX3_REGULATES_P14_ARF | 4.82e-04 | 6 | 81 | 2 | MM15545 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 4.95e-04 | 64 | 81 | 4 | M200 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 5.25e-04 | 65 | 81 | 4 | M39682 | |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 6.63e-04 | 30 | 81 | 3 | MM15173 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 6.72e-04 | 7 | 81 | 2 | MM1573 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 8.04e-04 | 32 | 81 | 3 | M39521 | |
| Pathway | PID_E2F_PATHWAY | 8.15e-04 | 73 | 81 | 4 | M40 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 8.93e-04 | 8 | 81 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 8.93e-04 | 8 | 81 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 8.93e-04 | 8 | 81 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 8.93e-04 | 8 | 81 | 2 | M46443 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 9.49e-04 | 272 | 81 | 7 | M29619 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.11e-03 | 136 | 81 | 5 | MM14848 | |
| Pathway | WP_MISMATCH_REPAIR | 1.14e-03 | 9 | 81 | 2 | MM15932 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.14e-03 | 9 | 81 | 2 | M47451 | |
| Pathway | REACTOME_RRNA_PROCESSING | 1.15e-03 | 205 | 81 | 6 | M27685 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DDX47 UTP6 PDS5B RANBP1 WDR36 ZC3H13 RPS6KA3 CANX NASP RBM28 AHSA1 RUVBL2 EFTUD2 LIG1 MSH6 MFAP1 GTF2I MDN1 CEBPZ SMARCA2 PDCD11 KMT2A DDX21 | 9.32e-12 | 1318 | 106 | 23 | 30463901 |
| Pubmed | UTP6 PDS5B WDR36 ZC3H13 CANX NSD1 SPAG9 RBM28 MSH6 GTF2I IGF2R MDN1 CEBPZ SMARCA2 PDCD11 KMT2A DDX21 | 1.51e-11 | 653 | 106 | 17 | 22586326 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | DDX47 WDR36 ZC3H13 CANX ZKSCAN8 RBM28 EFTUD2 MSH6 MFAP1 GTF2I MDN1 CEBPZ SMARCA2 PDCD11 KMT2A DDX21 | 5.02e-11 | 605 | 106 | 16 | 28977666 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX47 UTP6 PDS5B RANBP1 WDR36 CANX PCLO NASP SMARCAD1 AHSA1 RUVBL2 EFTUD2 MSH6 GTF2I IGF2R MDN1 CEBPZ G3BP2 PDCD11 BOD1L1 DDX21 ATP2B1 | 2.90e-10 | 1425 | 106 | 22 | 30948266 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | WDR36 MTRES1 CANX PCLO PSMB7 SCYL1 SPAG9 NUDCD3 RBM28 MTFR1L MDN1 MIA2 NDUFAF1 G3BP2 BRD7 FAM169A PDCD11 HERC1 SLC30A9 DDX21 SUCO BCL2L13 | 7.18e-10 | 1496 | 106 | 22 | 32877691 |
| Pubmed | RANBP1 NSD1 NASP SPAG9 SHTN1 RUVBL2 CREBBP MSH6 GTF2I CEBPZ PDCD11 KMT2A BOD1L1 EP300 | 1.42e-09 | 549 | 106 | 14 | 38280479 | |
| Pubmed | DDX47 PDS5B WDR36 PSMB7 SMARCAD1 AHSA1 RUVBL2 CREBBP MSH6 MFAP1 GTF2I MDN1 ZNF532 ZNF451 SMARCA2 KMT2A BOD1L1 EP300 | 1.72e-09 | 1014 | 106 | 18 | 32416067 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PDS5B TSHZ3 ZKSCAN8 NSD1 NASP SMARCAD1 MSH6 GTF2I ZNF451 BRD7 FAM169A KMT2A BOD1L1 PRDM15 | 5.19e-09 | 608 | 106 | 14 | 36089195 |
| Pubmed | DDX47 CCPG1 WDR36 ZC3H13 RBM28 RUVBL2 ZFY EFTUD2 MFAP1 GTF2I MDN1 CEBPZ G3BP2 PDCD11 KMT2A DDX21 | 6.37e-09 | 847 | 106 | 16 | 35850772 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RANBP1 ZC3H13 CANX PSMB7 NASP RBM28 RUVBL2 EFTUD2 MSH6 GTF2I MDN1 G3BP2 SMARCA2 BOD1L1 DDX21 ATP2B1 | 6.37e-09 | 847 | 106 | 16 | 35235311 |
| Pubmed | RANBP1 TSHZ3 ERF CANX PSMB7 SPAG9 RBM28 RUVBL2 CREBBP PRDM1 MFAP1 GTF2I ZNF451 G3BP2 BRD7 SMARCA2 PDCD11 KMT2A HERC1 EP300 | 1.10e-08 | 1429 | 106 | 20 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B ZC3H13 NASP SPAG9 SMARCAD1 ZFX EFTUD2 LIG1 MSH6 MFAP1 GTF2I MDN1 SMARCA2 KMT2A DDX21 | 1.41e-08 | 774 | 106 | 15 | 15302935 |
| Pubmed | CCPG1 WDR36 MAP2 ZC3H13 CANX SMARCAD1 NUDCD3 RBM28 EFTUD2 MFAP1 IGF2R MDN1 NDUFAF1 CEBPZ ZNF451 PDCD11 SLC30A9 DDX21 SUCO ATP2B1 | 2.13e-08 | 1487 | 106 | 20 | 33957083 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | CCPG1 CLGN CANX MSH6 IGF2R MDN1 FAM169A SLC30A9 DDX21 SUCO ATP2B1 | 2.20e-08 | 375 | 106 | 11 | 32788342 |
| Pubmed | 2.22e-08 | 57 | 106 | 6 | 18022353 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | PDS5B VGLL3 WDR36 CANX L1CAM ZKSCAN8 KMT2E EFTUD2 IGF1R IGF2R MIA2 PTPRK ZNF532 CEBPZ ZNF451 SLC30A9 ATP2B1 RNF111 | 2.41e-08 | 1203 | 106 | 18 | 29180619 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX47 UTP6 PDS5B RANBP1 WDR36 SMARCAD1 RBM28 RUVBL2 CREBBP EFTUD2 MSH6 MFAP1 GTF2I MDN1 CEBPZ SMARCA2 PDCD11 DDX21 ATP2B1 | 2.56e-08 | 1353 | 106 | 19 | 29467282 |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 31669559 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DDX47 BDP1 PDS5B MAP2 NASP AK9 IGF1R DNAH12 MDN1 KMT2A HERC1 MMP19 | 4.15e-08 | 497 | 106 | 12 | 36774506 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DDX47 WDR36 CANX NASP RBM28 AHSA1 RUVBL2 EFTUD2 LIG1 MSH6 GTF2I MDN1 CEBPZ PDCD11 BOD1L1 DDX21 | 5.46e-08 | 989 | 106 | 16 | 36424410 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DDX47 WDR36 ERF ZC3H13 ZKSCAN8 NSD1 RBM28 RUVBL2 ZFX EFTUD2 MFAP1 GTF2I MDN1 CEBPZ PDCD11 KMT2A DDX21 EP300 | 7.22e-08 | 1294 | 106 | 18 | 30804502 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RANBP1 MAP2 RPS6KA3 PSMB7 SCYL1 NASP SPAG9 SMARCAD1 NUDCD3 SHTN1 AHSA1 RUVBL2 EFTUD2 SPC24 LIG1 MSH6 GTF2I HERC1 KIF13A | 8.01e-08 | 1455 | 106 | 19 | 22863883 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DDX47 UTP6 PDS5B WDR36 ZKSCAN8 RBM28 RUVBL2 MSH6 MDN1 CEBPZ G3BP2 PDCD11 HSF2 DDX21 | 8.19e-08 | 759 | 106 | 14 | 35915203 |
| Pubmed | Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300. | 1.10e-07 | 4 | 106 | 3 | 17707401 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 1.24e-07 | 349 | 106 | 10 | 25665578 | |
| Pubmed | 1.63e-07 | 272 | 106 | 9 | 31010829 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP1 WDR36 NASP SPAG9 NUDCD3 SHTN1 AHSA1 EFTUD2 SPC24 MSH6 GTF2I FAM169A KMT2A BOD1L1 DDX21 | 1.63e-07 | 934 | 106 | 15 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B WDR36 ZC3H13 NSD1 RBM28 EFTUD2 MFAP1 GTF2I CEBPZ ZNF451 BRD7 PDCD11 KMT2A BOD1L1 DDX21 | 2.13e-07 | 954 | 106 | 15 | 36373674 |
| Pubmed | ERF MYT1 ZKSCAN8 CREBBP IKZF4 ZFX ZFY GTF2I ZNF532 BRD7 SMARCA2 KMT2A RNF111 | 2.64e-07 | 709 | 106 | 13 | 22988430 | |
| Pubmed | DDX47 WDR36 PSMB7 NASP RBM28 AHSA1 RUVBL2 EFTUD2 MSH6 CEBPZ G3BP2 FAM169A PDCD11 DDX21 ATP2B1 | 2.67e-07 | 971 | 106 | 15 | 33306668 | |
| Pubmed | DDX47 RANBP1 CLGN WDR36 RPS6KA3 CANX PSMB7 RBM28 EFTUD2 MSH6 GTF2I MDN1 CEBPZ G3BP2 PDCD11 KMT2A SLC30A9 ATP2B1 | 3.49e-07 | 1440 | 106 | 18 | 30833792 | |
| Pubmed | ERF ZC3H13 RPS6KA3 COBLL1 NASP LIG1 MSH6 GTF2I TMF1 KIF13A PSRC1 | 4.20e-07 | 503 | 106 | 11 | 16964243 | |
| Pubmed | 4.28e-07 | 222 | 106 | 8 | 37071664 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX47 UTP6 PDS5B WDR36 CANX RBM28 RUVBL2 EFTUD2 MFAP1 IGF2R MDN1 CEBPZ PDCD11 DDX21 ATP2B1 | 5.22e-07 | 1024 | 106 | 15 | 24711643 |
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 17970752 | ||
| Pubmed | 5.60e-07 | 157 | 106 | 7 | 30186101 | ||
| Pubmed | 6.37e-07 | 234 | 106 | 8 | 36243803 | ||
| Pubmed | 6.59e-07 | 419 | 106 | 10 | 15635413 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | PDS5B WDR36 NSD1 RUVBL2 ZFX ZFY MSH6 GTF2I MDN1 SMARCA2 KMT2A | 7.40e-07 | 533 | 106 | 11 | 30554943 |
| Pubmed | 7.49e-07 | 425 | 106 | 10 | 24999758 | ||
| Pubmed | DDX47 WDR36 RPS6KA3 COBLL1 RBM28 RUVBL2 MFAP1 HABP4 GTF2I CEBPZ TCHHL1 ZNF451 G3BP2 BRD7 PDCD11 KMT2A DDX21 | 8.60e-07 | 1371 | 106 | 17 | 36244648 | |
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 9.55e-07 | 7 | 106 | 3 | 21079652 | |
| Pubmed | PDS5B RANBP1 HDAC4 PSMB7 RBM28 AHSA1 RUVBL2 CREBBP LIG1 MSH6 GTF2I G3BP2 SMARCA2 KMT2A EP300 | 1.32e-06 | 1103 | 106 | 15 | 34189442 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DDX47 UTP6 WDR36 ZC3H13 CANX RBM28 AHSA1 RUVBL2 EFTUD2 MSH6 MFAP1 GTF2I CEBPZ G3BP2 PDCD11 DDX21 | 1.34e-06 | 1257 | 106 | 16 | 36526897 |
| Pubmed | RANBP1 CLGN WDR36 CANX NASP EFTUD2 G3BP2 PDCD11 DDX21 ATP2B1 | 1.62e-06 | 463 | 106 | 10 | 34901782 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDS5B RANBP1 HDAC4 NASP SPAG9 AHSA1 RUVBL2 EFTUD2 MSH6 MFAP1 IGF1R GTF2I NDUFAF1 G3BP2 HERC1 DDX21 | 1.76e-06 | 1284 | 106 | 16 | 17353931 |
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 9300697 | ||
| Pubmed | Placing the HIRA histone chaperone complex in the chromatin landscape. | 2.41e-06 | 31 | 106 | 4 | 23602572 | |
| Pubmed | DDX47 RANBP1 WDR36 ZC3H13 RBM28 RUVBL2 EFTUD2 MFAP1 GTF2I CEBPZ PDCD11 DDX21 | 2.47e-06 | 731 | 106 | 12 | 29298432 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 3.08e-06 | 289 | 106 | 8 | 23752268 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 3.12e-06 | 33 | 106 | 4 | 26864203 | |
| Pubmed | 3.25e-06 | 10 | 106 | 3 | 11163245 | ||
| Pubmed | 3.48e-06 | 75 | 106 | 5 | 25593309 | ||
| Pubmed | 3.56e-06 | 506 | 106 | 10 | 30890647 | ||
| Pubmed | 3.89e-06 | 210 | 106 | 7 | 16565220 | ||
| Pubmed | TSHZ3 VGLL3 RIPOR2 ZC3H13 NSD1 NUDCD3 HABP4 IGF1R ZNF451 CIAO2A PRDM15 BCL2L13 EP300 PSRC1 RNF111 | 4.28e-06 | 1215 | 106 | 15 | 15146197 | |
| Pubmed | CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder. | 4.46e-06 | 11 | 106 | 3 | 36385105 | |
| Pubmed | 4.98e-06 | 37 | 106 | 4 | 24583282 | ||
| Pubmed | PDS5B ERF KDM4C ZC3H13 MYT1 ZKSCAN8 PRDM1 MSH6 GTF2I ZNF451 BRD7 SMARCA2 | 6.82e-06 | 808 | 106 | 12 | 20412781 | |
| Pubmed | PDS5B RANBP1 MTRES1 PCLO RYR2 MFAP1 MDN1 MIA2 CEBPZ TCHHL1 FAM169A KMT2A BOD1L1 DDX21 USP1 ATP2B1 | 7.67e-06 | 1442 | 106 | 16 | 35575683 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 7.80e-06 | 153 | 106 | 6 | 26365490 | |
| Pubmed | Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling. | 8.49e-06 | 332 | 106 | 8 | 29053956 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 8.51e-06 | 440 | 106 | 9 | 34244565 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 9.04e-06 | 157 | 106 | 6 | 30686591 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 9.20e-06 | 2 | 106 | 2 | 34845315 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19729597 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31046797 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22222883 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 39287984 | ||
| Pubmed | Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene. | 9.20e-06 | 2 | 106 | 2 | 1691708 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8188262 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8188695 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12205094 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20717166 | ||
| Pubmed | Mapping the human ZFX locus to Xp21.3 by in situ hybridization. | 9.20e-06 | 2 | 106 | 2 | 2497060 | |
| Pubmed | Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY. | 9.20e-06 | 2 | 106 | 2 | 2041734 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25893291 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8318216 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11559821 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 32576962 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19822209 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24522976 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 9.20e-06 | 2 | 106 | 2 | 21847097 | |
| Pubmed | [Expression of Zfx in mouse testicular spermatogenic cells]. | 9.20e-06 | 2 | 106 | 2 | 38602753 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 9.20e-06 | 2 | 106 | 2 | 34813504 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12716983 | ||
| Pubmed | Intron/exon structure confirms that mouse Zfy1 and Zfy2 are members of the ZFY gene family. | 9.20e-06 | 2 | 106 | 2 | 9126493 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20301699 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24639469 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 37816914 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 9.20e-06 | 2 | 106 | 2 | 11438528 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10918613 | ||
| Pubmed | Evolution of the Zfx and Zfy genes: rates and interdependence between the genes. | 9.20e-06 | 2 | 106 | 2 | 8487630 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22336232 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 35502657 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31898871 | ||
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 9.20e-06 | 2 | 106 | 2 | 30888860 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 34523068 | ||
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 9.20e-06 | 2 | 106 | 2 | 27881443 | |
| Interaction | NUP43 interactions | PDS5B RANBP1 WDR36 ERF ZC3H13 PSMB7 NSD1 SMARCAD1 RBM28 RYR2 ZFX MFAP1 GTF2I ZNF532 CEBPZ FAM169A PDCD11 KMT2A BOD1L1 HSF2 | 8.07e-11 | 625 | 106 | 20 | int:NUP43 |
| Interaction | ANOS1 interactions | TSHZ3 WDR36 TAF1A ZKSCAN8 NSD1 RBM28 CEBPZ PDCD11 KMT2A DDX21 PRDM15 | 2.43e-10 | 143 | 106 | 11 | int:ANOS1 |
| Interaction | CHD4 interactions | DDX47 TSHZ3 WDR36 CANX ZKSCAN8 NASP SPAG9 SMARCAD1 RBM28 RUVBL2 IKZF4 EFTUD2 MSH6 MFAP1 GTF2I MDN1 SMARCA2 PDCD11 KMT2A DDX21 EP300 | 1.57e-08 | 938 | 106 | 21 | int:CHD4 |
| Interaction | PARP1 interactions | PDS5B WDR36 HDAC4 CANX NSD1 SMARCAD1 NUDCD3 RBM28 RUVBL2 CREBBP EFTUD2 LIG1 MSH6 MFAP1 MDN1 CEBPZ ZNF451 BRD7 FAM169A SMARCA2 PDCD11 DDX21 USP1 EP300 | 6.37e-08 | 1316 | 106 | 24 | int:PARP1 |
| Interaction | MEN1 interactions | DDX47 UTP6 PDS5B CCPG1 WDR36 ZC3H13 SCYL1 SMARCAD1 RBM28 RUVBL2 ZFY EFTUD2 MFAP1 GTF2I MDN1 CEBPZ G3BP2 PDCD11 KMT2A BOD1L1 DDX21 | 7.65e-08 | 1029 | 106 | 21 | int:MEN1 |
| Interaction | KHDRBS1 interactions | AMPH HDAC4 MATN2 COBLL1 PSMB7 SMARCAD1 RUVBL2 CREBBP MIA2 BRD7 SMARCA2 DDX21 EP300 | 8.18e-08 | 373 | 106 | 13 | int:KHDRBS1 |
| Interaction | ZNF330 interactions | PDS5B WDR36 NSD1 SMARCAD1 RBM28 MSH6 MFAP1 CEBPZ BRD7 FAM169A PDCD11 KMT2A DDX21 PRDM15 | 9.13e-08 | 446 | 106 | 14 | int:ZNF330 |
| Interaction | CENPA interactions | PDS5B TSHZ3 ZC3H13 NSD1 RUVBL2 MSH6 GTF2I CEBPZ ZNF451 BRD7 SMARCA2 PDCD11 KMT2A | 9.26e-08 | 377 | 106 | 13 | int:CENPA |
| Interaction | NR2C2 interactions | DDX47 UTP6 PDS5B RANBP1 WDR36 HDAC4 ZC3H13 RPS6KA3 CANX NASP RBM28 AHSA1 RUVBL2 EFTUD2 LIG1 MSH6 MFAP1 GTF2I MDN1 CEBPZ SMARCA2 PDCD11 KMT2A DDX21 | 2.09e-07 | 1403 | 106 | 24 | int:NR2C2 |
| Interaction | H3C1 interactions | PDS5B KDM4C RPS6KA3 COBLL1 TAF1A PSMB7 ZKSCAN8 NSD1 NASP SPAG9 RBM28 RUVBL2 CREBBP EFTUD2 MSH6 BRD7 SMARCA2 KMT2A EP300 | 2.13e-07 | 901 | 106 | 19 | int:H3C1 |
| Interaction | RBBP4 interactions | TSHZ3 HDAC4 RPS6KA3 NASP SPAG9 KMT2E RUVBL2 CREBBP EFTUD2 GTF2I ZNF532 BRD7 SMARCA2 KMT2A EP300 | 3.19e-07 | 573 | 106 | 15 | int:RBBP4 |
| Interaction | SIRT7 interactions | UTP6 PDS5B WDR36 ZC3H13 CANX NSD1 SPAG9 RBM28 MSH6 GTF2I IGF2R MDN1 CEBPZ SMARCA2 PDCD11 KMT2A DDX21 | 3.31e-07 | 744 | 106 | 17 | int:SIRT7 |
| Interaction | H3-3A interactions | PDS5B TSHZ3 KDM4C RPS6KA3 NSD1 NASP SPAG9 SMARCAD1 CREBBP MSH6 GTF2I ZNF451 BRD7 KMT2A BOD1L1 PRDM15 EP300 | 3.64e-07 | 749 | 106 | 17 | int:H3-3A |
| Interaction | RPL23AP32 interactions | 3.77e-07 | 87 | 106 | 7 | int:RPL23AP32 | |
| Interaction | CIT interactions | DDX47 UTP6 PDS5B RANBP1 CLGN WDR36 ZC3H13 CANX PCLO RBM28 RUVBL2 EFTUD2 MSH6 MFAP1 GTF2I DNAH12 CEBPZ G3BP2 SMARCA2 PDCD11 KMT2A BOD1L1 HERC1 DDX21 | 3.82e-07 | 1450 | 106 | 24 | int:CIT |
| Interaction | H1-2 interactions | HDAC4 TAF1A NSD1 NASP RUVBL2 EFTUD2 LIG1 IGF2R CEBPZ BRD7 PDCD11 KMT2A BOD1L1 DDX21 PRDM15 ATP2B1 | 3.93e-07 | 666 | 106 | 16 | int:H1-2 |
| Interaction | CHD3 interactions | DDX47 WDR36 ZC3H13 ZKSCAN8 RBM28 CREBBP EFTUD2 MSH6 HABP4 GTF2I MDN1 CEBPZ SMARCA2 PDCD11 KMT2A DDX21 EP300 | 4.22e-07 | 757 | 106 | 17 | int:CHD3 |
| Interaction | DNAJC9 interactions | WDR36 ZC3H13 SMARCAD1 RBM28 EFTUD2 HABP4 CEBPZ BRD7 PDCD11 DDX21 EP300 | 4.60e-07 | 296 | 106 | 11 | int:DNAJC9 |
| Interaction | CSNK2A1 interactions | BDP1 ZC3H13 RPS6KA3 CANX L1CAM SMARCAD1 RUVBL2 CREBBP EFTUD2 LIG1 MSH6 MFAP1 IGF2R MS4A1 KMT2A DDX21 ATP2B1 EP300 RNF111 | 5.25e-07 | 956 | 106 | 19 | int:CSNK2A1 |
| Interaction | SIN3A interactions | HDAC4 SMARCAD1 KMT2E CREBBP IKZF4 EFTUD2 GTF2I SMARCA2 KMT2A BOD1L1 CIAO2A EP300 | 7.60e-07 | 380 | 106 | 12 | int:SIN3A |
| Interaction | FBXO22 interactions | DDX47 BDP1 PDS5B MAP2 KDM4C NASP AK9 EFTUD2 IGF1R DNAH12 MDN1 KMT2A HERC1 MMP19 | 9.17e-07 | 540 | 106 | 14 | int:FBXO22 |
| Interaction | OBSL1 interactions | DDX47 UTP6 PDS5B WDR36 MAP2 CANX PCLO PSMB7 RBM28 RUVBL2 IKZF4 EFTUD2 MFAP1 MDN1 CEBPZ G3BP2 PDCD11 DDX21 | 1.03e-06 | 902 | 106 | 18 | int:OBSL1 |
| Interaction | FGFBP1 interactions | WDR36 TAF1A ZKSCAN8 RBM28 CEBPZ BRD7 PDCD11 KMT2A DDX21 PRDM15 | 1.04e-06 | 257 | 106 | 10 | int:FGFBP1 |
| Interaction | RPL3 interactions | HDAC4 KDM4C MATN2 TAF1A ZKSCAN8 SPAG9 RBM28 CREBBP EFTUD2 CEBPZ G3BP2 BRD7 PDCD11 KMT2A DDX21 PRDM15 | 1.14e-06 | 722 | 106 | 16 | int:RPL3 |
| Interaction | ZNF48 interactions | 1.21e-06 | 149 | 106 | 8 | int:ZNF48 | |
| Interaction | DDX23 interactions | PDS5B WDR36 ZC3H13 SCYL1 SPAG9 RBM28 EFTUD2 MSH6 MFAP1 CEBPZ PDCD11 DDX21 EP300 | 1.43e-06 | 480 | 106 | 13 | int:DDX23 |
| Interaction | XRCC6 interactions | SPARC WDR36 CANX NSD1 NASP SMARCAD1 AHSA1 RUVBL2 CREBBP EFTUD2 MSH6 MFAP1 GTF2I BRD7 KMT2A BOD1L1 DDX21 EP300 | 1.54e-06 | 928 | 106 | 18 | int:XRCC6 |
| Interaction | POLR1G interactions | PDS5B WDR36 TAF1A NSD1 SMARCAD1 RBM28 LIG1 MFAP1 MDN1 CEBPZ PDCD11 KMT2A DDX21 | 1.76e-06 | 489 | 106 | 13 | int:POLR1G |
| Interaction | NOP2 interactions | DDX47 WDR36 HDAC4 TAF1A RBM28 EFTUD2 CEBPZ G3BP2 BRD7 PDCD11 DDX21 EP300 | 1.96e-06 | 416 | 106 | 12 | int:NOP2 |
| Interaction | H3C3 interactions | PDS5B TSHZ3 ZKSCAN8 NSD1 NASP SMARCAD1 MSH6 GTF2I BRD7 FAM169A KMT2A BOD1L1 PRDM15 | 2.01e-06 | 495 | 106 | 13 | int:H3C3 |
| Interaction | SMC1A interactions | DDX47 PDS5B SCYL1 SPAG9 SMARCAD1 EFTUD2 MSH6 BRD7 PDCD11 KIF13A MGARP EP300 | 2.05e-06 | 418 | 106 | 12 | int:SMC1A |
| Interaction | WWTR1 interactions | RANBP1 SPAG9 SHTN1 RUVBL2 CREBBP MSH6 GTF2I CEBPZ PDCD11 KMT2A USP1 EP300 | 2.27e-06 | 422 | 106 | 12 | int:WWTR1 |
| Interaction | POLR1E interactions | WDR36 CANX NSD1 SMARCAD1 RBM28 CREBBP MFAP1 MDN1 CEBPZ PDCD11 KMT2A | 2.37e-06 | 350 | 106 | 11 | int:POLR1E |
| Interaction | RPL31 interactions | PDS5B WDR36 HDAC4 ZC3H13 NSD1 RBM28 AHSA1 ZFX EFTUD2 MFAP1 CEBPZ G3BP2 PDCD11 DDX21 PRDM15 | 2.70e-06 | 680 | 106 | 15 | int:RPL31 |
| Interaction | AP2M1 interactions | DDX47 AMPH RPS6KA3 L1CAM AHSA1 RUVBL2 EFTUD2 MFAP1 BRD7 KIF13A EP300 RNF111 | 2.75e-06 | 430 | 106 | 12 | int:AP2M1 |
| Interaction | NIFK interactions | WDR36 TAF1A NSD1 RBM28 EFTUD2 MFAP1 HABP4 MDN1 CEBPZ BRD7 PDCD11 DDX21 | 2.82e-06 | 431 | 106 | 12 | int:NIFK |
| Interaction | KPNA2 interactions | CANX NASP SPAG9 RUVBL2 CREBBP EFTUD2 MSH6 BRD7 SMARCA2 BOD1L1 DDX21 USP1 EP300 | 3.38e-06 | 519 | 106 | 13 | int:KPNA2 |
| Interaction | WDR5 interactions | DDX47 PDS5B WDR36 CANX SPAG9 AHSA1 RUVBL2 CREBBP EFTUD2 GTF2I G3BP2 SMARCA2 PDCD11 KMT2A BOD1L1 HSF2 DDX21 USP1 EP300 | 4.24e-06 | 1101 | 106 | 19 | int:WDR5 |
| Interaction | ZNF467 interactions | 4.76e-06 | 179 | 106 | 8 | int:ZNF467 | |
| Interaction | YY1 interactions | HDAC4 SMARCAD1 RBM28 KMT2E RUVBL2 CREBBP EFTUD2 MFAP1 GTF2I BRD7 KMT2A EP300 | 4.80e-06 | 454 | 106 | 12 | int:YY1 |
| Interaction | PPARG interactions | HDAC4 KDM4C NSD1 RUVBL2 CREBBP EFTUD2 GTF2I BRD7 SMARCA2 EP300 | 5.10e-06 | 307 | 106 | 10 | int:PPARG |
| Interaction | SMARCC1 interactions | VGLL3 SCYL1 SPAG9 SMARCAD1 CREBBP EFTUD2 MSH6 BRD7 SMARCA2 KMT2A EP300 | 5.74e-06 | 384 | 106 | 11 | int:SMARCC1 |
| Interaction | APOBEC3C interactions | 6.57e-06 | 187 | 106 | 8 | int:APOBEC3C | |
| Interaction | COIL interactions | DDX47 PDS5B WDR36 SCYL1 NSD1 SMARCAD1 RBM28 AHSA1 MSH6 MFAP1 CEBPZ G3BP2 PDCD11 | 6.59e-06 | 552 | 106 | 13 | int:COIL |
| Interaction | DHX40 interactions | 6.73e-06 | 249 | 106 | 9 | int:DHX40 | |
| Interaction | SRPK3 interactions | 7.38e-06 | 190 | 106 | 8 | int:SRPK3 | |
| Interaction | CHAF1A interactions | NASP SMARCAD1 RUVBL2 CREBBP EFTUD2 LIG1 MSH6 GTF2I MDN1 SMARCA2 | 7.75e-06 | 322 | 106 | 10 | int:CHAF1A |
| Interaction | PEA15 interactions | 7.99e-06 | 90 | 106 | 6 | int:PEA15 | |
| Interaction | MDM2 interactions | RANBP1 MAP2 RPS6KA3 CANX RUVBL2 CREBBP RYR2 EFTUD2 IGF1R GTF2I MS4A1 G3BP2 SMARCA2 EP300 | 9.02e-06 | 658 | 106 | 14 | int:MDM2 |
| Interaction | CTBP1 interactions | TSHZ3 HDAC4 RPS6KA3 PCLO CREBBP IKZF4 IGF1R IGF2R KMT2A EP300 RNF111 | 9.70e-06 | 406 | 106 | 11 | int:CTBP1 |
| Interaction | SMC3 interactions | DDX47 PDS5B SPAG9 SMARCAD1 EFTUD2 MSH6 MDN1 BRD7 SMARCA2 PDCD11 EP300 | 1.02e-05 | 408 | 106 | 11 | int:SMC3 |
| Interaction | DDX18 interactions | 1.07e-05 | 334 | 106 | 10 | int:DDX18 | |
| Interaction | MECP2 interactions | DDX47 PDS5B WDR36 MAP2 ZC3H13 CANX TAF1A ZKSCAN8 NSD1 RBM28 RUVBL2 EFTUD2 MSH6 MFAP1 ZNF532 CEBPZ SMARCA2 PDCD11 DDX21 EP300 | 1.09e-05 | 1287 | 106 | 20 | int:MECP2 |
| Interaction | RPS6KA5 interactions | 1.11e-05 | 144 | 106 | 7 | int:RPS6KA5 | |
| Interaction | RNF2 interactions | UTP6 PDS5B WDR36 CANX PCLO RBM28 RUVBL2 ZFY EFTUD2 MFAP1 GTF2I CEBPZ G3BP2 PDCD11 KMT2A ATP2B1 | 1.16e-05 | 866 | 106 | 16 | int:RNF2 |
| Interaction | LSG1 interactions | 1.20e-05 | 203 | 106 | 8 | int:LSG1 | |
| Interaction | MAN1B1 interactions | 1.23e-05 | 97 | 106 | 6 | int:MAN1B1 | |
| Interaction | SNIP1 interactions | UTP6 RBM28 RUVBL2 CREBBP EFTUD2 MFAP1 ZNF451 G3BP2 SMARCA2 DDX21 EP300 | 1.25e-05 | 417 | 106 | 11 | int:SNIP1 |
| Interaction | CBX4 interactions | 1.29e-05 | 205 | 106 | 8 | int:CBX4 | |
| Interaction | SS18L1 interactions | 1.31e-05 | 98 | 106 | 6 | int:SS18L1 | |
| Interaction | SRSF6 interactions | WDR36 ZC3H13 ZKSCAN8 RBM28 EFTUD2 CEBPZ BRD7 PDCD11 KMT2A DDX21 PRDM15 EP300 | 1.35e-05 | 503 | 106 | 12 | int:SRSF6 |
| Interaction | SUMO2 interactions | HDAC4 RPS6KA3 SMARCAD1 EFTUD2 MSH6 GTF2I MDN1 ZNF451 BOD1L1 HSF2 DDX21 EP300 RNF111 | 1.36e-05 | 591 | 106 | 13 | int:SUMO2 |
| Interaction | RPL36 interactions | HDAC4 MATN2 TAF1A ZKSCAN8 NSD1 RBM28 EFTUD2 CEBPZ G3BP2 PDCD11 KMT2A DDX21 | 1.37e-05 | 504 | 106 | 12 | int:RPL36 |
| Interaction | DGKZ interactions | 1.38e-05 | 99 | 106 | 6 | int:DGKZ | |
| Interaction | MAGEB2 interactions | WDR36 TAF1A ZKSCAN8 NSD1 RBM28 CEBPZ BRD7 PDCD11 DDX21 PRDM15 | 1.56e-05 | 349 | 106 | 10 | int:MAGEB2 |
| Interaction | HDAC11 interactions | 1.72e-05 | 154 | 106 | 7 | int:HDAC11 | |
| Interaction | ILF3 interactions | SPARC WDR36 HDAC4 COBLL1 TAF1A NSD1 SMARCAD1 RBM28 EFTUD2 CEBPZ G3BP2 BRD7 PDCD11 DDX21 PRDM15 EP300 | 1.76e-05 | 896 | 106 | 16 | int:ILF3 |
| Interaction | BIRC3 interactions | DDX47 UTP6 PDS5B RANBP1 WDR36 CANX NASP SMARCAD1 AHSA1 RUVBL2 EFTUD2 MSH6 GTF2I MDN1 CEBPZ G3BP2 PDCD11 DDX21 ATP2B1 EP300 | 1.84e-05 | 1334 | 106 | 20 | int:BIRC3 |
| Interaction | RBBP5 interactions | ZC3H13 RUVBL2 CREBBP EFTUD2 ZNF532 SMARCA2 KMT2A BOD1L1 EP300 | 2.09e-05 | 287 | 106 | 9 | int:RBBP5 |
| Interaction | GTPBP4 interactions | DDX47 WDR36 RBM28 EFTUD2 HABP4 CEBPZ G3BP2 BRD7 PDCD11 DDX21 EP300 | 2.18e-05 | 443 | 106 | 11 | int:GTPBP4 |
| Interaction | KPNA4 interactions | 2.51e-05 | 225 | 106 | 8 | int:KPNA4 | |
| Interaction | SIRT6 interactions | DDX47 WDR36 RBM28 RUVBL2 CREBBP EFTUD2 MSH6 GTF2I CEBPZ G3BP2 BRD7 SMARCA2 EP300 | 2.58e-05 | 628 | 106 | 13 | int:SIRT6 |
| Interaction | RFC4 interactions | 2.68e-05 | 227 | 106 | 8 | int:RFC4 | |
| Interaction | HNRNPU interactions | DDX47 WDR36 HDAC4 RPS6KA3 NASP SPAG9 SMARCAD1 RBM28 AHSA1 RUVBL2 EFTUD2 CEBPZ BRD7 TMF1 PDCD11 DDX21 EP300 | 2.73e-05 | 1035 | 106 | 17 | int:HNRNPU |
| Interaction | PRMT1 interactions | DDX47 PDS5B ZC3H13 PSMB7 SCYL1 NASP RBM28 RUVBL2 EFTUD2 HABP4 GTF2I ZNF451 G3BP2 HSF2 DDX21 EP300 | 2.74e-05 | 929 | 106 | 16 | int:PRMT1 |
| Interaction | NLE1 interactions | 2.76e-05 | 228 | 106 | 8 | int:NLE1 | |
| Interaction | FDPS interactions | 2.90e-05 | 167 | 106 | 7 | int:FDPS | |
| Interaction | GCM1 interactions | 2.93e-05 | 68 | 106 | 5 | int:GCM1 | |
| Interaction | ACP5 interactions | 2.97e-05 | 34 | 106 | 4 | int:ACP5 | |
| Interaction | SNRNP40 interactions | WDR36 ZC3H13 SMARCAD1 NUDCD3 RBM28 EFTUD2 ZNF532 CEBPZ ZNF451 G3BP2 PDCD11 KMT2A DDX21 | 2.99e-05 | 637 | 106 | 13 | int:SNRNP40 |
| Interaction | ZFY interactions | 3.01e-05 | 12 | 106 | 3 | int:ZFY | |
| Interaction | KDM1A interactions | TSHZ3 KDM4C MYT1 SMARCAD1 NUDCD3 SHTN1 RUVBL2 EFTUD2 PRDM1 MSH6 GTF2I ZNF532 ZNF451 SMARCA2 TMF1 EP300 | 3.20e-05 | 941 | 106 | 16 | int:KDM1A |
| Interaction | KIF20A interactions | DDX47 PDS5B WDR36 PCLO SPAG9 RUVBL2 EFTUD2 MFAP1 MIA2 G3BP2 SMARCA2 BOD1L1 TNNC2 HERC1 KIF13A DDX21 CDH9 | 3.36e-05 | 1052 | 106 | 17 | int:KIF20A |
| Interaction | CBX3 interactions | PDS5B WDR36 ZC3H13 COBLL1 NSD1 SMARCAD1 EFTUD2 LIG1 MFAP1 GTF2I ZNF451 KMT2A EP300 | 3.45e-05 | 646 | 106 | 13 | int:CBX3 |
| Interaction | RPL14 interactions | HDAC4 MATN2 TAF1A ZKSCAN8 RBM28 EFTUD2 CEBPZ G3BP2 BRD7 PDCD11 DDX21 EP300 | 3.48e-05 | 554 | 106 | 12 | int:RPL14 |
| Interaction | AP1B1 interactions | 3.64e-05 | 237 | 106 | 8 | int:AP1B1 | |
| Interaction | PRMT5 interactions | HDAC4 KDM4C NASP SPAG9 AHSA1 EFTUD2 PRDM1 G3BP2 BRD7 SMARCA2 EP300 | 3.82e-05 | 471 | 106 | 11 | int:PRMT5 |
| Interaction | POLR1C interactions | 3.92e-05 | 311 | 106 | 9 | int:POLR1C | |
| Interaction | GRWD1 interactions | WDR36 RBM28 KMT2E RUVBL2 EFTUD2 BRD7 PDCD11 KMT2A DDX21 EP300 | 4.01e-05 | 390 | 106 | 10 | int:GRWD1 |
| Interaction | RPL30 interactions | HDAC4 KDM4C MATN2 TAF1A RBM28 EFTUD2 GTF2I CEBPZ G3BP2 DDX21 PRDM15 | 4.04e-05 | 474 | 106 | 11 | int:RPL30 |
| Interaction | BMI1 interactions | ZC3H13 CANX NSD1 RUVBL2 CREBBP EFTUD2 HABP4 IGF1R G3BP2 SMARCA2 PDCD11 KMT2A EP300 | 4.24e-05 | 659 | 106 | 13 | int:BMI1 |
| Interaction | ETS1 interactions | 4.32e-05 | 121 | 106 | 6 | int:ETS1 | |
| Interaction | NOP56 interactions | WDR36 CANX NSD1 RBM28 EFTUD2 MFAP1 CEBPZ BRD7 SMARCA2 PDCD11 DDX21 EP300 | 4.58e-05 | 570 | 106 | 12 | int:NOP56 |
| Interaction | TAF6 interactions | 4.60e-05 | 245 | 106 | 8 | int:TAF6 | |
| Interaction | HDAC2 interactions | RPS6KA3 CANX SPAG9 SMARCAD1 RUVBL2 CREBBP IKZF4 EFTUD2 PRDM1 GTF2I G3BP2 SMARCA2 KMT2A DDX21 EP300 | 4.63e-05 | 865 | 106 | 15 | int:HDAC2 |
| Interaction | MTF1 interactions | 4.74e-05 | 123 | 106 | 6 | int:MTF1 | |
| Interaction | KPNA3 interactions | 5.02e-05 | 248 | 106 | 8 | int:KPNA3 | |
| Interaction | TACC2 interactions | 5.35e-05 | 77 | 106 | 5 | int:TACC2 | |
| Interaction | HECTD1 interactions | DDX47 UTP6 PDS5B WDR36 ZKSCAN8 RBM28 RUVBL2 EFTUD2 MSH6 MDN1 CEBPZ G3BP2 PDCD11 HSF2 DDX21 EP300 | 5.46e-05 | 984 | 106 | 16 | int:HECTD1 |
| Interaction | EED interactions | DDX47 UTP6 PDS5B ZC3H13 SCYL1 NSD1 SMARCAD1 RBM28 AHSA1 RUVBL2 EFTUD2 LIG1 MSH6 IGF1R GTF2I IGF2R CEBPZ SMARCA2 PDCD11 DDX21 | 5.71e-05 | 1445 | 106 | 20 | int:EED |
| Cytoband | 5q35 | 1.29e-03 | 23 | 106 | 2 | 5q35 | |
| Cytoband | 6q21 | 1.46e-03 | 96 | 106 | 3 | 6q21 | |
| Cytoband | 3p14.3 | 2.20e-03 | 30 | 106 | 2 | 3p14.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q21 | 2.83e-03 | 121 | 106 | 3 | chr6q21 | |
| Cytoband | Xp11.21 | 2.99e-03 | 35 | 106 | 2 | Xp11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q22 | 3.61e-03 | 132 | 106 | 3 | chr15q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p14 | 4.26e-03 | 140 | 106 | 3 | chr3p14 | |
| GeneFamily | WD repeat domain containing|UTPB complex | 2.32e-04 | 6 | 72 | 2 | 1225 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.32e-04 | 34 | 72 | 3 | 487 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.19e-03 | 13 | 72 | 2 | 1186 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.05e-03 | 17 | 72 | 2 | 486 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.05e-03 | 17 | 72 | 2 | 1197 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.12e-03 | 718 | 72 | 9 | 28 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.30e-03 | 18 | 72 | 2 | 91 | |
| GeneFamily | PWWP domain containing | 3.43e-03 | 22 | 72 | 2 | 1147 | |
| GeneFamily | PHD finger proteins | 5.55e-03 | 90 | 72 | 3 | 88 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B AMPH HDAC4 KDM4C RPS6KA3 SPAG9 CREBBP MSH6 IGF1R IGF2R MDN1 MIA2 PTPRK ZNF451 FAM169A SMARCA2 DDX21 SUCO ATP2B1 | 1.48e-09 | 856 | 106 | 19 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 CCPG1 RIPOR2 MAP2 PCLO MYT1 L1CAM KMT2E SHTN1 RYR2 IKZF4 MDN1 PTPRK FAM169A BOD1L1 HERC1 KIF13A ATP2B1 | 4.50e-07 | 1106 | 106 | 18 | M39071 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | SPAG9 ZFX HABP4 IGF1R CEBPZ ZNF451 BRD7 FAM169A TMF1 BOD1L1 SUCO ATP2B1 EP300 | 3.75e-06 | 680 | 106 | 13 | M41089 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 PDS5B MATN2 SMARCAD1 SHTN1 MFAP1 CEBPZ SMARCA2 TMF1 DDX21 SUCO USP1 | 1.41e-05 | 656 | 106 | 12 | M18979 |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 1.64e-05 | 198 | 106 | 7 | M3195 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | HDAC4 ZC3H13 CANX NASP SHTN1 CREBBP MIA2 SMARCA2 CIAO2A RNF111 | 2.03e-05 | 467 | 106 | 10 | M1347 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | HDAC4 ZC3H13 CANX NASP SHTN1 CREBBP MIA2 SMARCA2 CIAO2A RNF111 | 2.75e-05 | 484 | 106 | 10 | MM999 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | TSHZ3 CLGN MAP2 CANX COBLL1 PCLO SHTN1 HABP4 IGF1R G3BP2 BRD7 KIF13A SUCO USP1 | 2.80e-05 | 946 | 106 | 14 | M39169 |
| Coexpression | ABRAMSON_INTERACT_WITH_AIRE | 3.03e-05 | 44 | 106 | 4 | M2536 | |
| Coexpression | ENK_UV_RESPONSE_EPIDERMIS_DN | 4.42e-05 | 512 | 106 | 10 | M4508 | |
| Coexpression | DORMOY_ELAVL1_TARGETS | 5.02e-05 | 18 | 106 | 3 | M2323 | |
| Coexpression | PYEON_HPV_POSITIVE_TUMORS_UP | 5.72e-05 | 101 | 106 | 5 | M7738 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 PDS5B RIPOR2 RPS6KA3 NSD1 KMT2E JAML CREBBP PRDM1 G3BP2 SMARCA2 TMF1 KMT2A BOD1L1 HERC1 USP1 EP300 | 9.93e-05 | 1492 | 106 | 17 | M40023 |
| Coexpression | GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP | 1.08e-04 | 185 | 106 | 6 | M6148 | |
| Coexpression | GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN | 1.18e-04 | 188 | 106 | 6 | M367 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 1.20e-04 | 578 | 106 | 10 | M2368 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN | 1.22e-04 | 24 | 106 | 3 | M19520 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | BDP1 AMPH RIPOR2 MAP2 PCLO L1CAM RYR2 IKZF4 PTPRK FAM169A ATP2B1 | 1.32e-04 | 703 | 106 | 11 | M39070 |
| Coexpression | GSE25087_FETAL_VS_ADULT_TREG_DN | 1.33e-04 | 192 | 106 | 6 | M4643 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 1.40e-04 | 194 | 106 | 6 | M7306 | |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 1.44e-04 | 195 | 106 | 6 | M7310 | |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 1.44e-04 | 195 | 106 | 6 | M7382 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 1.56e-04 | 597 | 106 | 10 | MM1309 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 1.57e-04 | 198 | 106 | 6 | M6123 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | DDX47 SPARC KMT2E ZFX ZFY MFAP1 PTPRK G3BP2 FAM169A TMF1 HSF2 DDX21 | 1.58e-04 | 844 | 106 | 12 | M41129 |
| Coexpression | GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP | 1.61e-04 | 199 | 106 | 6 | M3217 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN | 1.61e-04 | 199 | 106 | 6 | M8430 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN | 1.61e-04 | 199 | 106 | 6 | M3175 | |
| Coexpression | GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP | 1.66e-04 | 200 | 106 | 6 | M5831 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_UP | 1.66e-04 | 200 | 106 | 6 | M4819 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN | 1.66e-04 | 200 | 106 | 6 | M10091 | |
| Coexpression | GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP | 1.66e-04 | 200 | 106 | 6 | M9734 | |
| Coexpression | HALLMARK_E2F_TARGETS | 1.66e-04 | 200 | 106 | 6 | M5925 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 1.66e-04 | 200 | 106 | 6 | M7839 | |
| Coexpression | GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN | 1.66e-04 | 200 | 106 | 6 | M7836 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 1.70e-04 | 201 | 106 | 6 | M1571 | |
| Coexpression | HADDAD_B_LYMPHOCYTE_PROGENITOR | 1.81e-04 | 290 | 106 | 7 | M939 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 1.86e-04 | 389 | 106 | 8 | M39102 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 2.21e-04 | 399 | 106 | 8 | M40939 | |
| Coexpression | AMUNDSON_RESPONSE_TO_ARSENITE | 2.70e-04 | 219 | 106 | 6 | M262 | |
| Coexpression | LEE_BMP2_TARGETS_DN | UTP6 RANBP1 WDR36 HDAC4 NASP AHSA1 RUVBL2 MSH6 MDN1 PDCD11 DDX21 USP1 | 2.96e-04 | 904 | 106 | 12 | M2325 |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 3.16e-04 | 318 | 106 | 7 | M41707 | |
| Coexpression | JEPSEN_SMRT_TARGETS | 3.21e-04 | 33 | 106 | 3 | MM745 | |
| Coexpression | JEPSEN_SMRT_TARGETS | 3.21e-04 | 33 | 106 | 3 | M1773 | |
| Coexpression | LEE_BMP2_TARGETS_DN | UTP6 RANBP1 WDR36 HDAC4 NASP AHSA1 RUVBL2 MSH6 MDN1 PDCD11 DDX21 USP1 | 3.54e-04 | 922 | 106 | 12 | MM1068 |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 3.68e-04 | 232 | 106 | 6 | MM1019 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 3.77e-04 | 432 | 106 | 8 | M41149 | |
| Coexpression | ALONSO_METASTASIS_EMT_UP | 3.83e-04 | 35 | 106 | 3 | M8191 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | PDS5B MAP2 CANX ZKSCAN8 NSD1 CREBBP RYR2 ZFX GTF2I ZNF451 SUCO ATP2B1 | 7.83e-08 | 330 | 104 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | RIPOR2 SPARC ZC3H13 MATN2 COBLL1 PSMB7 NASP KMT2E CREBBP IKZF4 PTPRK G3BP2 SMARCA2 TNNC2 HERC1 ATP2B1 | 1.62e-06 | 797 | 104 | 16 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 RANBP1 PCLO NASP SMARCAD1 MSH6 MIA2 CEBPZ BRD7 FAM169A TMF1 USP1 RNF111 | 2.02e-06 | 532 | 104 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.40e-06 | 204 | 104 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | BDP1 WDR36 MAP2 TAF1A ZKSCAN8 NASP SMARCAD1 MDN1 ZNF532 CEBPZ FAM169A PDCD11 KMT2A BOD1L1 CFAP119 HSF2 DDX21 SUCO USP1 CDH11 | 2.86e-05 | 1479 | 104 | 20 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | RIPOR2 ZC3H13 MATN2 PSMB7 NASP KMT2E IKZF4 PTPRK HERC1 ATP2B1 | 2.96e-05 | 404 | 104 | 10 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | RIPOR2 SPARC ZC3H13 MATN2 COBLL1 PSMB7 NASP KMT2E CREBBP IKZF4 PTPRK SMARCA2 HERC1 ATP2B1 | 3.51e-05 | 799 | 104 | 14 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | ZC3H13 MATN2 PSMB7 NASP KMT2E CREBBP IKZF4 IGF2R PTPRK ZNF451 G3BP2 SMARCA2 HERC1 ATP2B1 | 3.60e-05 | 801 | 104 | 14 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.67e-05 | 186 | 104 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | ZC3H13 PSMB7 NASP KMT2E CREBBP RYR2 IKZF4 ZFX PTPRK ZNF451 G3BP2 FAM169A HERC1 ATP2B1 | 3.75e-05 | 804 | 104 | 14 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | UTP6 RIPOR2 ZC3H13 PSMB7 NASP KMT2E CREBBP PRDM1 PTPRK ZNF451 G3BP2 FAM169A HERC1 ATP2B1 | 3.86e-05 | 806 | 104 | 14 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | BDP1 RANBP1 MAP2 PCLO MYT1 NASP KMT2E SHTN1 VPS9D1 HABP4 MDN1 CEBPZ FAM169A TMF1 USP1 | 8.70e-05 | 983 | 104 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | UTP6 RANBP1 AMPH CCPG1 COBLL1 NASP SMARCAD1 RUVBL2 SPC24 LIG1 MDN1 BRD7 FAM169A CFAP119 HSF2 USP1 PSRC1 IQCG | 1.11e-04 | 1371 | 104 | 18 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | RIPOR2 ZC3H13 MATN2 PSMB7 NASP KMT2E CREBBP IKZF4 PTPRK ZNF451 SMARCA2 HERC1 ATP2B1 | 1.28e-04 | 790 | 104 | 13 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | WDR36 SHTN1 EFTUD2 PRDM1 MSH6 MDN1 CEBPZ ZNF451 FAM169A PDCD11 HSF2 DDX21 IQCG | 1.36e-04 | 795 | 104 | 13 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | WDR36 SHTN1 EFTUD2 PRDM1 MDN1 NDUFAF1 ZNF451 FAM169A PDCD11 HERC1 HSF2 DDX21 IQCG | 1.64e-04 | 810 | 104 | 13 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | RANBP1 ZC3H13 PSMB7 NASP SMARCAD1 RUVBL2 SPC24 LIG1 MDN1 CEBPZ FAM169A PDCD11 HSF2 DDX21 MGARP USP1 | 1.67e-04 | 1164 | 104 | 16 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | PDS5B MAP2 CANX ZKSCAN8 NSD1 SHTN1 CREBBP RYR2 ZFX GTF2I ZNF451 SUCO ATP2B1 | 1.80e-04 | 818 | 104 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.27e-04 | 249 | 104 | 7 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.88e-04 | 259 | 104 | 7 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 RANBP1 ZC3H13 CANX ZKSCAN8 NSD1 NASP SMARCAD1 LIG1 MSH6 MDN1 BRD7 FAM169A BOD1L1 HSF2 USP1 | 3.95e-04 | 1257 | 104 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.13e-04 | 275 | 104 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.31e-04 | 277 | 104 | 7 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.70e-04 | 281 | 104 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | TSHZ3 VGLL3 MAP2 MATN2 IKZF4 NDUFAF1 ZNF451 SMARCA2 TNNC2 KIF13A SUCO CDH11 | 4.92e-04 | 791 | 104 | 12 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 4.98e-04 | 469 | 104 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.18e-04 | 375 | 104 | 8 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 5.86e-04 | 78 | 104 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_200 | 6.12e-04 | 139 | 104 | 5 | gudmap_dev gonad_e13.5_M_GermCell_Oct_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.16e-04 | 385 | 104 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | UTP6 ZC3H13 PSMB7 NASP SMARCAD1 KMT2E CREBBP IKZF4 ZFX ZNF451 G3BP2 HERC1 | 6.40e-04 | 815 | 104 | 12 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.81e-04 | 595 | 104 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BDP1 RANBP1 MAP2 ZC3H13 CANX ZKSCAN8 NSD1 NASP SMARCAD1 LIG1 MSH6 MDN1 BRD7 FAM169A BOD1L1 HSF2 USP1 | 7.03e-04 | 1459 | 104 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 7.12e-04 | 493 | 104 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 7.27e-04 | 395 | 104 | 8 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | 7.39e-04 | 396 | 104 | 8 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.52e-04 | 397 | 104 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | RANBP1 ZC3H13 PSMB7 NASP SMARCAD1 RUVBL2 SPC24 LIG1 MDN1 CEBPZ FAM169A PDCD11 HSF2 DDX21 MGARP USP1 | 8.36e-04 | 1347 | 104 | 16 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 8.69e-04 | 406 | 104 | 8 | gudmap_developingGonad_e16.5_epididymis_500 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-07 | 194 | 106 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 4.85e-07 | 198 | 106 | 7 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.01e-07 | 199 | 106 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.19e-07 | 200 | 106 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.19e-07 | 200 | 106 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 5.19e-07 | 200 | 106 | 7 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 5.19e-07 | 200 | 106 | 7 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 169 | 106 | 6 | 15a9183c838cc6384d7f5dfeae3d30602964c9b3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.19e-06 | 177 | 106 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.75e-06 | 187 | 106 | 6 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-06 | 190 | 106 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-06 | 192 | 106 | 6 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-06 | 194 | 106 | 6 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.30e-06 | 195 | 106 | 6 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.30e-06 | 195 | 106 | 6 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 7.30e-06 | 195 | 106 | 6 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 7.52e-06 | 196 | 106 | 6 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.74e-06 | 197 | 106 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.74e-06 | 197 | 106 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 7.97e-06 | 198 | 106 | 6 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-06 | 198 | 106 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 8.20e-06 | 199 | 106 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | HSPCs|World / Lineage and Cell class | 8.20e-06 | 199 | 106 | 6 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 8.20e-06 | 199 | 106 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 8.20e-06 | 199 | 106 | 6 | f30e9d3d095a1e12d759debe27540aad32861db6 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.20e-06 | 199 | 106 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.20e-06 | 199 | 106 | 6 | e3b69608c834bd8ce6bedde298a2763cc0d7d573 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.44e-06 | 200 | 106 | 6 | 97e47eb69d1d4cab45256acca9589837eb7817e7 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.44e-06 | 200 | 106 | 6 | 5d11a2c0021805e78d97dc1638bf73ca1faede66 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 8.44e-06 | 200 | 106 | 6 | cfec2f712b870797fab3b0770f16feaafd37e8d5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-05 | 158 | 106 | 5 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 4.30e-05 | 162 | 106 | 5 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 164 | 106 | 5 | b175258fb0885afd84d4a414c0ae441f880e8469 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 164 | 106 | 5 | 875d922eec7e3df0998ddf0c8c4dee2dcd5b23ca | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 164 | 106 | 5 | 8bcfc93220d7c99dddb32b7fa7fb9aec2a1c63fa | |
| ToppCell | ASK440-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.11e-05 | 168 | 106 | 5 | 127559d1a083c68cda9fce143afcc3eec168df17 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.87e-05 | 173 | 106 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-05 | 176 | 106 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-05 | 176 | 106 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-05 | 177 | 106 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-05 | 177 | 106 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.55e-05 | 177 | 106 | 5 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 7.47e-05 | 182 | 106 | 5 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.66e-05 | 183 | 106 | 5 | 956ff95aef9c5521b6a3ba7ac6df0aad242c1c35 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.66e-05 | 183 | 106 | 5 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.06e-05 | 185 | 106 | 5 | 847257d232b9993cad50c814fd4ffeef52385295 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.06e-05 | 185 | 106 | 5 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.27e-05 | 186 | 106 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-05 | 187 | 106 | 5 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.48e-05 | 187 | 106 | 5 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.70e-05 | 188 | 106 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 8.70e-05 | 188 | 106 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-05 | 98 | 106 | 4 | 95162072f3afc95e46f29db3d79ebd930bc09726 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 189 | 106 | 5 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.92e-05 | 189 | 106 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.92e-05 | 189 | 106 | 5 | 610d7cc1fc923dbd67d3b71f94d529a658982f87 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-05 | 189 | 106 | 5 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.92e-05 | 189 | 106 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue | 8.92e-05 | 189 | 106 | 5 | ac2995e599f3d1813218479dc515b1d612c0ef8b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-05 | 190 | 106 | 5 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.37e-05 | 191 | 106 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.37e-05 | 191 | 106 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.37e-05 | 191 | 106 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.37e-05 | 191 | 106 | 5 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.37e-05 | 191 | 106 | 5 | b978afe76754cc56e1672abca27be289bb56375b | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.60e-05 | 192 | 106 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.60e-05 | 192 | 106 | 5 | 5ef79faddb433c09ff36660d8bf7a3af5a67bf1d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.60e-05 | 192 | 106 | 5 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.84e-05 | 193 | 106 | 5 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.84e-05 | 193 | 106 | 5 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.84e-05 | 193 | 106 | 5 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.84e-05 | 193 | 106 | 5 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 193 | 106 | 5 | 5a201ee6f132357c9aacfbad3ae56ed9854c25fd | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 194 | 106 | 5 | f4c9fc53ae31d58096906d9305b0b4082512a7e9 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-04 | 194 | 106 | 5 | ae6d5cf4c825b29e677296df2c0985431c83b82e | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 194 | 106 | 5 | ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 194 | 106 | 5 | 5d60262a512590d60bc795d9a0e03c0219e3e15e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-04 | 194 | 106 | 5 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | E16.5|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-04 | 194 | 106 | 5 | 8a48f596cf1ca43718b9db661305c150e459f8d4 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.01e-04 | 194 | 106 | 5 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 195 | 106 | 5 | 841fde528ecb293e07b5e00e499d1e9f0b0dce14 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-04 | 195 | 106 | 5 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-04 | 195 | 106 | 5 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 195 | 106 | 5 | 06051de72b5c1e0d483a28b14dabd247dfca0ed9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-pDC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 195 | 106 | 5 | 3aa44633c72658545aa2b35bf9d532c62f36a451 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 195 | 106 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 1.03e-04 | 195 | 106 | 5 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-04 | 196 | 106 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.06e-04 | 196 | 106 | 5 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.06e-04 | 196 | 106 | 5 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 196 | 106 | 5 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.06e-04 | 196 | 106 | 5 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.06e-04 | 196 | 106 | 5 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.06e-04 | 196 | 106 | 5 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | myeloid-pro-pDC|myeloid / Lineage and Cell class | 1.06e-04 | 196 | 106 | 5 | 70daf4fabb68aecc5cc9f03d6f6495dd29b74a16 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.08e-04 | 197 | 106 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.08e-04 | 197 | 106 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | myeloid-CD34+_Monoblast|myeloid / Lineage and Cell class | 1.11e-04 | 198 | 106 | 5 | e26b98a8380e693110a97d8e5a353998f8d67c6d | |
| Computational | Neighborhood of MSH2 | 3.74e-05 | 28 | 74 | 4 | GNF2_MSH2 | |
| Computational | Genes in the cancer module 98. | 3.38e-04 | 393 | 74 | 10 | MODULE_98 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.75e-04 | 50 | 74 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Neighborhood of HDAC2 | 6.52e-04 | 280 | 74 | 8 | MORF_HDAC2 | |
| Computational | Neighborhood of RRM1 | 6.69e-04 | 102 | 74 | 5 | MORF_RRM1 | |
| Computational | Neighborhood of MSH2 | 8.03e-04 | 61 | 74 | 4 | MORF_MSH2 | |
| Computational | Neighborhood of CASP2 | 8.14e-04 | 27 | 74 | 3 | GCM_CASP2 | |
| Computational | Neighborhood of SMC1L1 | 8.54e-04 | 62 | 74 | 4 | MORF_SMC1L1 | |
| Computational | Neighborhood of MSH6 | 1.23e-03 | 31 | 74 | 3 | GNF2_MSH6 | |
| Computational | Genes in the cancer module 197. | 1.23e-03 | 174 | 74 | 6 | MODULE_197 | |
| Computational | Neighborhood of HAT1 | 1.27e-03 | 175 | 74 | 6 | MORF_HAT1 | |
| Drug | R165481 | 7.74e-07 | 16 | 106 | 4 | CID005459348 | |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; HL60; HG-U133A | 4.13e-06 | 198 | 106 | 8 | 1551_UP | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.18e-05 | 2 | 102 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 1.18e-05 | 2 | 102 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 1.18e-05 | 2 | 102 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 1.18e-05 | 2 | 102 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 1.18e-05 | 2 | 102 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.18e-05 | 2 | 102 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 1.18e-05 | 2 | 102 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 1.18e-05 | 2 | 102 | 2 | C0035934 | |
| Disease | prostate cancer (is_marker_for) | 1.76e-05 | 156 | 102 | 6 | DOID:10283 (is_marker_for) | |
| Disease | Leukemia, Myelocytic, Acute | 3.15e-05 | 173 | 102 | 6 | C0023467 | |
| Disease | Lewy Body Disease | 5.89e-05 | 22 | 102 | 3 | C0752347 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.13e-05 | 195 | 102 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Weaver syndrome | 1.18e-04 | 5 | 102 | 2 | C0265210 | |
| Disease | Bladder Neoplasm | 1.29e-04 | 140 | 102 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.33e-04 | 141 | 102 | 5 | C0005684 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 2.10e-04 | 84 | 102 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | Paroxysmal atrial fibrillation | 2.14e-04 | 156 | 102 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 2.14e-04 | 156 | 102 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.14e-04 | 156 | 102 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 2.40e-04 | 160 | 102 | 5 | C0004238 | |
| Disease | microcephaly (is_implicated_in) | 3.27e-04 | 8 | 102 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | Carcinoma, Transitional Cell | 3.89e-04 | 41 | 102 | 3 | C0007138 | |
| Disease | Adenoid Cystic Carcinoma | 4.09e-04 | 100 | 102 | 4 | C0010606 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 4.23e-04 | 181 | 102 | 5 | DOID:684 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 4.25e-04 | 101 | 102 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | triglycerides in large LDL measurement | 4.48e-04 | 43 | 102 | 3 | EFO_0022319 | |
| Disease | neuroblastoma (is_implicated_in) | 5.23e-04 | 10 | 102 | 2 | DOID:769 (is_implicated_in) | |
| Disease | treatment-resistant hypertension | 5.67e-04 | 109 | 102 | 4 | EFO_1002006 | |
| Disease | factor VIII measurement, coronary artery disease | 6.49e-04 | 113 | 102 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 6.93e-04 | 115 | 102 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 7.64e-04 | 12 | 102 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Small cell carcinoma of lung | 8.75e-04 | 54 | 102 | 3 | C0149925 | |
| Disease | ovary epithelial cancer (is_marker_for) | 9.00e-04 | 13 | 102 | 2 | DOID:2152 (is_marker_for) | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 9.00e-04 | 13 | 102 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | Sjogren's Syndrome | 9.00e-04 | 13 | 102 | 2 | C1527336 | |
| Disease | methylcobalamin deficiency type cblE, response to antineoplastic agent | 9.00e-04 | 13 | 102 | 2 | GO_0097327, MONDO_0009354 | |
| Disease | Sicca Syndrome | 9.00e-04 | 13 | 102 | 2 | C0086981 | |
| Disease | leukemia | 9.23e-04 | 55 | 102 | 3 | C0023418 | |
| Disease | Diffuse Large B-Cell Lymphoma | 9.23e-04 | 55 | 102 | 3 | C0079744 | |
| Disease | Acute Myeloid Leukemia, M1 | 9.47e-04 | 125 | 102 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 9.47e-04 | 125 | 102 | 4 | C1879321 | |
| Disease | triglycerides in LDL measurement | 9.73e-04 | 56 | 102 | 3 | EFO_0022320 | |
| Disease | nephroblastoma (is_implicated_in) | 1.05e-03 | 14 | 102 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | age at menarche | 1.08e-03 | 594 | 102 | 8 | EFO_0004703 | |
| Disease | triglycerides in IDL measurement | 1.08e-03 | 58 | 102 | 3 | EFO_0022149 | |
| Disease | total lipids in medium HDL measurement | 1.08e-03 | 58 | 102 | 3 | EFO_0022310 | |
| Disease | Endometrial Neoplasms | 1.08e-03 | 58 | 102 | 3 | C0014170 | |
| Disease | FEV/FEC ratio | UTP6 TSHZ3 HDAC4 MAP2 NSD1 NASP IKZF4 GTF2I DNAH12 HERC1 KIF13A ATP2B1 | 1.10e-03 | 1228 | 102 | 12 | EFO_0004713 |
| Disease | phospholipids in VLDL measurement | 1.13e-03 | 59 | 102 | 3 | EFO_0022301 | |
| Disease | total lipids in VLDL measurement | 1.19e-03 | 60 | 102 | 3 | EFO_0022314 | |
| Disease | Malignant neoplasm of breast | RANBP1 HDAC4 RPS6KA3 MSH6 IGF1R MIA2 ZNF532 G3BP2 BOD1L1 DNASE1L3 EP300 | 1.23e-03 | 1074 | 102 | 11 | C0006142 |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.25e-03 | 61 | 102 | 3 | C1961102 | |
| Disease | free cholesterol in VLDL measurement | 1.25e-03 | 61 | 102 | 3 | EFO_0022276 | |
| Disease | risk-taking behaviour | 1.34e-03 | 764 | 102 | 9 | EFO_0008579 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.37e-03 | 63 | 102 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | Schizoaffective disorder-bipolar type | 1.38e-03 | 16 | 102 | 2 | EFO_0009965 | |
| Disease | T-Cell Lymphoma | 1.38e-03 | 16 | 102 | 2 | C0079772 | |
| Disease | thyroid volume | 1.38e-03 | 16 | 102 | 2 | EFO_0004865 | |
| Disease | cholesterol in large VLDL measurement | 1.50e-03 | 65 | 102 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.50e-03 | 65 | 102 | 3 | EFO_0022230 | |
| Disease | breast carcinoma (is_marker_for) | 1.57e-03 | 66 | 102 | 3 | DOID:3459 (is_marker_for) | |
| Disease | total lipids in small VLDL | 1.64e-03 | 67 | 102 | 3 | EFO_0022148 | |
| Disease | JT interval | 1.73e-03 | 248 | 102 | 5 | EFO_0007885 | |
| Disease | Adrenocortical carcinoma | 1.75e-03 | 18 | 102 | 2 | C0206686 | |
| Disease | Myeloid Leukemia | 1.75e-03 | 18 | 102 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 1.75e-03 | 18 | 102 | 2 | C0023466 | |
| Disease | susceptibility to mononucleosis measurement | 1.78e-03 | 69 | 102 | 3 | EFO_0008403 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 1.93e-03 | 71 | 102 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | Congenital hernia of foramen of Morgagni | 1.95e-03 | 19 | 102 | 2 | C0265699 | |
| Disease | Lewy body dementia (is_marker_for) | 1.95e-03 | 19 | 102 | 2 | DOID:12217 (is_marker_for) | |
| Disease | Congenital hernia of foramen of Bochdalek | 1.95e-03 | 19 | 102 | 2 | C0265700 | |
| Disease | Endometrial Carcinoma | 2.01e-03 | 72 | 102 | 3 | C0476089 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.04e-03 | 154 | 102 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.29e-03 | 670 | 102 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | Congenital diaphragmatic hernia | 2.38e-03 | 21 | 102 | 2 | C0235833 | |
| Disease | amino acid measurement | 2.46e-03 | 678 | 102 | 8 | EFO_0005134 | |
| Disease | Parkinson Disease | 3.23e-03 | 85 | 102 | 3 | C0030567 | |
| Disease | Autism Spectrum Disorders | 3.23e-03 | 85 | 102 | 3 | C1510586 | |
| Disease | large artery stroke, coronary artery disease | 3.37e-03 | 25 | 102 | 2 | EFO_0001645, EFO_0005524 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DEEEVKAATTEPTEV | 381 | Q9BXK5 | |
| KVEPISEGESEEVEV | 426 | P50548 | |
| TEASQPIVEEEETKT | 11 | Q9H0S4 | |
| STELKTEIKEEEDQP | 1016 | Q09472 | |
| PEVTDATEEIDKNLE | 971 | A6H8Y1 | |
| PEVIDATEEIDLEET | 1026 | A6H8Y1 | |
| KTPEVIDAIEEIEID | 1076 | A6H8Y1 | |
| TPEVIDATEEIDKDL | 1131 | A6H8Y1 | |
| LTEDTEEPKKTDVAE | 631 | Q9NPI1 | |
| EVEISVSLAKDEPDT | 116 | O95433 | |
| PNVLEESIKELEQEE | 1546 | Q92793 | |
| ETSSQPKNEEDIEII | 251 | P11836 | |
| ELVPIETTQSEEEEK | 21 | Q5RIA9 | |
| EKPNTLEELEVVSES | 51 | Q9H5X1 | |
| SLEEIDEKEELSEVP | 416 | Q53SF7 | |
| TQKEEIPEEELAEDV | 1076 | P20020 | |
| IEEKSELQPTEVESR | 291 | Q8IWF9 | |
| EAEELEATVPQEKVI | 526 | P49418 | |
| TVEEEGIPKETDIEI | 31 | Q9H095 | |
| VSLPEQEIKTLEEDE | 31 | P43487 | |
| DEEEENIESKVTKPV | 251 | Q9NW13 | |
| DIPQEETEEEEVSTV | 1421 | Q9NTI5 | |
| EQPVTEDESIEEIFE | 171 | Q96L73 | |
| TEKITPLEIEVLEET | 256 | Q99436 | |
| EEKSEVQAIIESTPE | 336 | O60271 | |
| KIVEPEVVGESDSEV | 106 | P55081 | |
| EVEIQTVKTEEDQDP | 5226 | Q9NU22 | |
| VQVKQEPIESDEEEA | 556 | P56524 | |
| KAIEEELQEIASEPT | 796 | O00339 | |
| VPVQEIEIDSTTELD | 111 | Q8IVD9 | |
| EEINPQTEEVSIKEI | 36 | P51812 | |
| DSTVPDEIQEVVIET | 831 | Q15751 | |
| ELVPIETTQSEEEEK | 21 | Q9BRT8 | |
| KVPELEVEEETQVQE | 276 | Q5JVS0 | |
| GTIDIEEVTENPKTE | 676 | P08069 | |
| SETLEITISEEEIKE | 1456 | Q9Y6V0 | |
| ITISEEEIKESQEER | 1461 | Q9Y6V0 | |
| VIRDEEEEETELPTV | 261 | Q99542 | |
| EEKIEEEPKDNATIT | 756 | Q6ZR08 | |
| ELPEVLSIEEEVEET | 596 | Q9H3R0 | |
| IDDIEEKTPISNEVE | 546 | Q8IZD2 | |
| EPETETALAEIITET | 701 | Q8IZD2 | |
| ETVKPVEVEEGESVV | 141 | P32004 | |
| ISDITEETEVEVPEL | 186 | Q9H019 | |
| SVIVQEPTEEKRQEE | 26 | Q5JRK9 | |
| SREEEDITVLVTPEK | 26 | Q6PGN9 | |
| EDNEIESEEEVQPKT | 221 | P52701 | |
| VIVSIEEKPKEVSEE | 266 | P49321 | |
| PSEKEDEDIITSVEN | 2026 | Q8NFC6 | |
| DDDTIKSQEEDQPII | 2856 | Q8NFC6 | |
| EEQAVTPQKEELETV | 251 | A1A4V9 | |
| STIEAEEQKIPEDSI | 81 | Q9ULG6 | |
| TTPETSVKEIDELVE | 156 | Q13609 | |
| ESETKTEELKPQVEE | 201 | Q9UN86 | |
| EVALDITSSEEKPDV | 66 | Q9Y375 | |
| ELVPIETTQSEEEEK | 21 | Q5JTY5 | |
| ELVPIETTQSEEEEK | 21 | Q4V339 | |
| DDVIEEVEDSKPDTT | 36 | P27824 | |
| DTVTVKISVEDADEP | 366 | P55287 | |
| KAVDSSSEEIEVEVP | 631 | Q9Y6X4 | |
| ETEKASSEAPEELIV | 101 | Q8TDB4 | |
| EQESAEPKTVEEEES | 3626 | Q03164 | |
| TEEIAEEEETVFPKA | 41 | Q9NR30 | |
| SQLEVPATEEIKETD | 971 | P78347 | |
| EEETPKESLTEAEVA | 156 | P18858 | |
| SEPEVATKQELQEEE | 201 | P18858 | |
| TPEEESDTLEKELSV | 1856 | Q92736 | |
| DTAVVKISVEDIDEP | 366 | Q9ULB4 | |
| EKDDSVIVEDSLSEP | 121 | Q9H2S9 | |
| IVKKLETEETVPETD | 656 | Q03701 | |
| ETEETVPETDVETKK | 661 | Q03701 | |
| KESEETIIQTDEDVP | 476 | Q15262 | |
| SVIVQEPTEEKRQEE | 26 | Q7Z2X7 | |
| SEVLSSVDKPIEVDE | 471 | Q03933 | |
| TSELDPEKEQEIETI | 416 | Q96PC5 | |
| EIVSNIPKATEEIED | 1306 | Q9H1H9 | |
| DQDSEDEVLTIPEVK | 2406 | P11717 | |
| IKEETEIIEGEVVEI | 131 | Q9Y230 | |
| AVSEPIEETTVETEI | 781 | Q5TCS8 | |
| ELEIESQTEEQPTTK | 281 | Q9NYH9 | |
| TEEKILLDPNSEEVS | 656 | P51531 | |
| NKDTVIIVSEPSEDE | 116 | Q9H4L7 | |
| KLESVSEDPTQLEEV | 536 | Q96KG9 | |
| EELKGPVTDDEEVET | 6 | Q15573 | |
| EVIEEEEPSEKSEAT | 346 | Q86YT9 | |
| EDKEPTEQVAEIITE | 651 | P57071 | |
| EKATQPETTEEVTDL | 391 | A0MZ66 | |
| SVEEAETEQPQEKEI | 416 | Q8TE82 | |
| SEQEEELEDDPTVVK | 116 | Q9P0P8 | |
| EDDISVISVVEKEIL | 746 | O75626 | |
| EEASELKPVELDTSE | 546 | Q9Y4F9 | |
| PEEKSEEEIEIIEGQ | 556 | O14967 | |
| DVIEEIIKSEILDET | 571 | Q9H8M5 | |
| ETVDEDEEVDPALTV | 1011 | Q14690 | |
| TETSIKTEDDFPVIE | 701 | Q9Y4E5 | |
| NEEETEIKEDTKVPS | 1126 | Q9HCE3 | |
| KSEEVNETLVIPTEE | 376 | P82094 | |
| EVVDLTVDEDEPTVV | 381 | Q6ZNA4 | |
| QPESEDVEALEVEVE | 1971 | Q8IWN7 | |
| QEKEVDEDTTVTIPS | 121 | Q8NBT2 | |
| QEALPDETEVVEETV | 21 | P09486 | |
| VVDSSSLPEVKEEEQ | 856 | Q9UBS9 | |
| EEETKEVTVPLEDTT | 96 | Q63HK5 | |
| VSEPAEIQSEEEEIE | 1226 | P11137 | |
| PTKEELDAIIEEVDE | 51 | P02585 | |
| VIIPEQVLDSDVTEE | 91 | P17010 | |
| QEIQEVKTPEELETF | 516 | Q6PML9 | |
| LETKEPVTSEEEDES | 736 | Q5QJ38 | |
| LEEVETTKEAGETVP | 51 | Q9Y2B5 | |
| EVETIVQEEDTQPLT | 76 | Q15029 | |
| EVTLPSKQEEEDEEE | 56 | A8MV65 | |
| ISVPVQEDELSKVEE | 456 | O94782 | |
| DIKITKERTPESEEE | 126 | Q5T200 | |
| QTPEEDLVIVKVEED | 16 | Q15776 | |
| EIITDPLTSDIVSEE | 161 | P08048 | |
| EVSEETVEPSDELIE | 726 | Q8NI36 | |
| STPLEEVVDDLSEKT | 881 | Q9NR99 | |
| IQPEDAEEVVEVTTE | 216 | Q01538 |